Introduction {#sec1}
============

It is well known that isoindolinones are important structural motifs in natural products and pharmaceuticals. Among isoindolinones, the 3-substituted isoindolinone moiety is frequently found in a few alkaloids.^[@ref1]^ For example, nuevamine 1 is the first known isoindoloisoquinoline alkaloid and lennoxamine 2 is an isoindolobenzazepine alkaloid; both of them are isolated from *Berberis darwinii*.^[@ref2]^ Pestalachloride A 3 is an antifungal alkaloid, which is isolated from *Pestalotiopsis adust*.^[@ref3]^ Pagoclone 4 and pazinaclone 5 are anticonvulsant and anxiolytic drugs,^[@ref4]^ PD-172938 6 shows affinity toward dopamine D4 receptors,^[@ref5]^ and compound 7 is a non-nucleoside HIV-1 reverse transcriptase inhibitor ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}).^[@ref6]^ Apart from these drug candidates, the 3-substituted isoindolinones show many other biological activities, including antipsychotic,^[@ref7]^ antihypertensive,^[@ref8]^ antiulcer,^[@ref9]^ and anxiolytic^[@ref10]^ properties.

![Examples of naturally occurring and biologically active C(3)-substituted isoindolinones.](ao9b02853_0012){#fig1}

The development of a bond-forming reaction between electrophiles and nucleophiles needs a suitable catalyst system; various Lewis acids were successfully used for the activation of both electrophiles and nucleophiles.^[@ref11]^ On the other hand, acyliminium ions represent important electron-deficient carbocation intermediates in organic synthesis because they provide various biologically important natural and unnatural products via C--C and C-heteroatom bond-forming methodologies using an inter- or intramolecular path.^[@ref12],[@ref13]^ The removal of a good leaving group at the α-position of amides or lactams generates usually *N*-acyliminium ions, which act as more electron-deficient carbocations toward nucleophiles. In this regard, chiral thiourea derivatives,^[@ref14],[@ref15]^ superacidic reagents,^[@ref16]^ and Lewis^[@ref17]^ and Brønsted acidic^[@ref18]^ systems are used for the generation of *N*-acyliminium ions and subsequent amidoalkylation reactions ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}). In addition, utilization of transition metals, such as Au^I^/Ag^I^,^[@ref19]^ Sn(NTf)~4~,^[@ref20]^ and Pd^II^--Ag^I^,^[@ref21]^ for nucleophilic addition of γ-hydroxy lactams, Cu^II^-catalyzed reaction for the addition of *N*-acyliminium ions and diaryl malonote,^[@ref22]^ and Pd for an asymmetric reaction between malonates and dihydroisoquinolines^[@ref23]^ is noteworthy. Herein, we report an efficient Ni^II^-promoted amidoalkylation reaction for the synthesis of 3-substituted isoindolinones involving various γ-hydroxy lactams and a variety of C/N/O/S nucleophiles in both intermolecular and intramolecular amidoalkylation manners.

![Catalytic α-Amidoalkylation Reaction](ao9b02853_0005){#sch1}

Results and Discussion {#sec2}
======================

Initially, for the template study of the amidoalkylation reaction of **1a** and **2a** to **3a**, a broad set of reaction parameters were examined including the solvent, temperature, and different Lewis acid catalysts. Ni(ClO~4~)~2~·6H~2~O was found to be superior, as only 10 mol % of the catalyst was required to perform the amidoalkylation reaction at 100 °C and a quantitative yield of the product **3a** was obtained in 3 h ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 1). Ni(ClO~4~)~2~·6H~2~O remained catalytically active for a wide range of temperatures (80--120 °C) and for polar solvents like 1,2-dichloroethane (DCE), tetrahydrofuran (THF), and acetonitrile (entries 1--5). However, in toluene, the reaction did not proceed at all even after 12 h (entry 6). Anhydrous SnCl~2~ or SnCl~4~ was also effective for the amidoalkylation reaction (entries 7 and 8). Moreover, Lewis acidic Sc(OTf)~3~, Y(OTf)~3~, Yb(OTf), La(OTf)~3~, In(OTf)~3~, and Cu(OTf)~2~ were also found to be less efficient to catalyze the amidoalkylation compared to Ni(ClO~4~)~2~·6H~2~O (entries 9--14). From the above screening, the supremacy of Ni(ClO~4~)~2~·6H~2~O over conventional Lewis acids including several widely used metal triflates to carry out the amidoalkylation reaction was established.

###### Screening and Optimization of Reaction Conditions[a](#t1fn1){ref-type="table-fn"}

![](ao9b02853_0003){#fx1}

  entry   catalyst               solvent   temp (°C)   *t* (h)   yield%[b](#t1fn2){ref-type="table-fn"}
  ------- ---------------------- --------- ----------- --------- ----------------------------------------
  1       Ni(CI0~4~)~2~·6H~2~O   DCE       100         3         92
  2       Ni(CI0~4~)~2~·6H~2~O   DCE       80          3         83
  3       Ni(CI0~4~)~2~·6H~2~O   DCE       120         3         92
  4       Ni(CI0~4~)~2~·6H~2~O   THF       100         5         67
  5       Ni(CI0~4~)~2~·6H~2~O   CH~3~CN   100         5         82
  6       Ni(CI0~4~)~2~·6H~2~O   toluene   100         12        0
  7       SnCI~2~                DCE       100         12        0
  8       SnCI~4~                DCE       100         12        0
  9       Sc(OTf)~3~             DCE       100         12        75
  10      Y(OTf)~3~              DCE       100         12        32
  11      Yb(OTf)~3~             DCE       100         12        45
  12      La(OTf)~3~             DCE       100         12        23
  13      ln(OTf)~3~             DCE       100         12        18
  14      Cu(OTf)~2~             DCE       100         12        23

Reaction conditions: **1a** (0.2 mmol), **2a** (0.24 mmol), the catalyst (0.02 mmol) in the solvent (2 mL), a sealed tube.

Isolated yield.

After having the optimized conditions in hand, we next investigated the scope and limitation of the method. First, a variety of ketone derivatives (**1a**--**o**) were exposed to standard reaction conditions, and the results are summarized in [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}. A variety of electronically rich, neutral and poor ketones were well tolerated under the standard conditions and afforded the corresponding substituted isoindolinones (**3a**--**k**) in good to excellent yields (85--96%). Various functional groups of ketones such as fluoro, chloro, bromo, nitro, cyano, alkyl, methoxy, and acetoxy, were well tolerated and produced the corresponding substituted isoindolinones (**3a**--**k**). Under standard reaction conditions, moderate to good yields (82--87%) were achieved for the reaction between 1-(4-nitrophenyl)ethan-1-one and various γ-hydroxy lactam derivatives \[3-hydroxy-2-isopropylisoindolin-1-one, 3-hydroxy-2-phenylisoindolin-1-one, 3-hydroxy-2-(*p*-tolyl)isoindolin-1-one, 2-(4-fluorobenzyl)-3-hydroxyisoindolin-1-one, 2-(4-chlorobenzyl)-3-hydroxyisoindolin-1-one, 3-hydroxy-2-(4-methylbenzyl)isoindolin-1-one, and 2-(4-chlorophenethyl)-3-hydroxyisoindolin-1-one\]. On the other hand, a relatively lower yield (82%) of the product was achieved in the case of 2-(4-fluorobenzyl)-3-hydroxyisoindolin-1-one, which suggests that both the generation and stability of the *N*-acyliminium ion are important for the reaction.

###### Substrate Scope of the Intermolecular Amidoalkylation Reaction via Ketone Nucleophiles Catalyzed by Ni(ClO~4~)~2~·6H~2~O[a](#t2fn1){ref-type="table-fn"}

![](ao9b02853_0007){#fx2}

Reaction conditions: **1** (0.2 mmol), **2** (0.24 mmol), Ni(ClO~4~)~2~·6H~2~O (10 mol %), DCE (2 mL), 100 °C, a sealed tube, 3 h, isolated yield.

Then, we investigated the scope of the amidoalkylation reaction with respect to arenes. Thus, 2-benzyl-3-hydroxyisoindolin-1-one was reacted with various arene derivatives (1,3,5-trimethoxybenzene, mesitylene, and 2-methylthiophene) under the standard conditions, and the results are presented in [Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}. As shown in [Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}, it is evident that arene derivatives were well tolerated to optimized conditions and afforded 3-substituted isoindolinones (**5a**--**c**) in good yields (90--92%).

###### Substrate Scope of the Intermolecular Amidoalkylation Reaction via Arene Nucleophiles Catalyzed by Ni(ClO~4~)~2~·6H~2~O[a](#t3fn1){ref-type="table-fn"}

![](ao9b02853_0008){#fx3}

Reaction conditions: **1** (0.2 mmol), **4** (0.24 mmol), Ni(ClO~4~)~2~·6H~2~O (10 mol %), DCE (2 mL), 100 °C, a sealed tube, 3 h, isolated yield.

The success of the above intermolecular amidoalkylation reaction encouraged us to investigate intramolecular cyclizations of the *N*-acyliminium ions for the synthesis of \[2,3\]-fused isoindolinone derivatives. Under standard reaction conditions, moderate to good yields (82--91%) were achieved for the reaction with a variety of γ-hydroxy-*N*-phenylethyl-lactams ([Table [4](#tbl4){ref-type="other"}](#tbl4){ref-type="other"}). On the other hand, electron-poor arenes such as 3-hydroxy-2-(4-(trifluoromethyl)phenethyl)isoindolin-1-one remained unreactive toward the cyclization reaction.

###### Substrate Scope of the Intramolecular Amidoalkylation Reaction Catalyzed by Ni(ClO~4~)~2~·6H~2~O[a](#t4fn1){ref-type="table-fn"}

![](ao9b02853_0011){#fx4}

Reaction conditions: **1** (0.2 mmol), **4** (0.24 mmol), Ni(ClO~4~)~2~·6H~2~O (10 mol %), DCE (2 mL), 100 °C, a sealed tube, 3 h, isolated yield.

Encouraged by the transformation proceeding with different carbon (ketones and arenes) nucleophiles in the intermolecular and intramolecular amidoalkylation discussed above, we tried to broaden the scope with different types of oxygen (alcohols), sulfur (thiols), and nitrogen (amines) nucleophiles. First, the reaction with different oxygen nucleophiles was tested, and the results are summarized in [Table [5](#tbl5){ref-type="other"}](#tbl5){ref-type="other"}. Thus, a variety of primary and secondary alcohols were well tolerated under the standard conditions and afforded the corresponding 3-O-substituted isoindolinones (**8a**--**l**) with moderate to excellent yields (85--92%). Under standard reaction conditions, moderate to good yields (85--93%) were achieved for the reaction between ethanol and various γ-hydroxy lactam derivatives \[2-(4-fluorobenzyl)-3-hydroxyisoindolin-1-one, 3-hydroxy-2-(4-methylbenzyl)isoindolin-1-one, 3-hydroxy-2-(*p*-tolyl)isoindolin-1-one, 3-hydroxy-2-phenylisoindolin-1-one, 2-(4-chlorophenethyl)-3-hydroxyisoindolin-1-one, and 2-(4-chlorophenyl)-3-hydroxyisoindolin-1-one\].

###### Substrate Scope of the Intermolecular Amidoalkylation Reaction via Alcohol Nucleophiles Catalyzed by Ni(ClO~4~)~2~·6H~2~O[a](#t5fn1){ref-type="table-fn"}

![](ao9b02853_0004){#fx5}

Reaction conditions: **1** (0.2 mmol), **4** (0.24 mmol), Ni(ClO~4~)~2~·6H~2~O (10 mol %), DCE (2 mL), 100 °C, a sealed tube, 3 h, isolated yield.

Similarly, sulfur nucleophiles like ethanethiol, propane-1-thiol, butane-1-thiol, pentane-1-thiol, heptane-1-thiol, propane-2-thiol, cyclopentanethiol, and 2-methylpropane-1-thiol were also found to provide 3-S-substituted isoindolinone products (**10a**--**h)** in good yields (85--92%). Additionally, in the α-amidoalkylation reaction of heteroatom nucleophiles, sulfur nucleophiles like phenylmethanethiol, *p*-tolylmethanethiol, (4-chlorophenyl)methanethiol, (4-(*tert*-butyl)phenyl)methanethiol, and ethyl 2-mercaptoacetate were also tested and the results were delightful, we could obtain the corresponding 3-S-substituted isoindolinones in good yield (85−94%). To further augment the reactivity, we conducted the reaction between propane-1-thiol and various γ-hydroxy lactam derivatives \[4-((1-hydroxy-3-oxoisoindolin-2-yl)methyl)benzonitrile, 3-hydroxy-2-phenylisoindolin-1-one, 3-hydroxy-2-(*p*-tolyl)isoindolin-1-one, 2-(4-chlorophenethyl)-3-hydroxyisoindolin-1-one, 3-hydroxy-2-phenethylisoindolin-1-one, 3-hydroxy-2-(4-methylphenethyl)isoindolin-1-one, and 3-hydroxy-2-(4-methoxybenzyl)isoindolin-1-one\].

Also, nitrogen nucleophiles like thiomorpholine, morpholine, phenylmethanamine, (4-fluorophenyl)methanamine, (4-chlorophenyl)methanamine, (4-bromophenyl)methanamine, (2-chlorophenyl)methanamine, *o*-tolylmethanamine, and furan-2-ylmethanamine were found to provide corresponding 3-N-substituted isoindolinone products (**12a**--**i**) in good yields (81--95%). Additionally, in the α-amidoalkylation reaction of heteroatom nucleophiles, we conducted the reaction between thiomorpholine and various γ-hydroxy lactam derivatives \[3-hydroxy-2-phenylisoindolin-1-one, 3-hydroxy-2-(*p*-tolyl)isoindolin-1-one, 3-hydroxy-2-isopropylisoindolin-1-one, 3-hydroxy-2-phenethylisoindolin-1-one, 3-hydroxy-2-(4-methoxyphenethyl)isoindolin-1-one, 2-(4-chlorophenethyl)-3-hydroxyisoindolin-1-one, 3-hydroxy-2-(4-methylphenethyl)isoindolin-1-one, 3-hydroxy-2-(4-methylbenzyl)isoindolin-1-one, and 2-(4-fluorobenzyl)-3-hydroxyisoindolin-1-one\] and obtained good yields (85--92%) ([Table [6](#tbl6){ref-type="other"}](#tbl6){ref-type="other"} and [7](#tbl7){ref-type="other"}).

###### Substrate Scope of the Intermolecular Amidoalkylation Reaction via Thiol Nucleophiles Catalyzed by Ni(ClO~4~)~2~·6H~2~O[a](#t6fn1){ref-type="table-fn"}

![](ao9b02853_0009){#fx6}

Reaction conditions: **1** (0.2 mmol), **4** (0.24 mmol), Ni(ClO~4~)~2~·6H~2~O (10 mol %), DCE (2 mL), 100 °C, a sealed tube, 3 h, isolated yield.

###### Substrate Scope of the Intermolecular Amidoalkylation Reaction via Amine Nucleophiles Catalyzed by Ni(ClO~4~)~2~·6H~2~O[a](#t7fn1){ref-type="table-fn"}

![](ao9b02853_0010){#fx7}

Reaction conditions: **1** (0.2 mmol), **4** (0.24 mmol), Ni(ClO~4~)~2~·6H~2~O (10 mol %), DCE (2 mL), 100 °C, a sealed tube, 3 h, isolated yield.

To demonstrate the scalability of this process, gram-scale reactions were performed ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}). 1-(4-Nitrophenyl)ethan-1-one, ethanol, propane-1-thiol, and thiomorpholine were well tolerated under the standard conditions and afforded the corresponding 3-substituted isoindolinones with good yields (85--96%).

![Gram-Scale Synthesis of 3-Substituted Isoindolinones](ao9b02853_0002){#sch2}

Based on these results and reported literature,^[@ref24]^ a possible reaction mechanism is proposed in [Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}. We propose that Ni(ClO~4~)~2~·6H~2~O acts as a Lewis acid to activate and facilitate the departure of a 3-hydroxyl group to form the acyliminium ions. The nucleophilic attack of different carbon (ketones and arenes) and heteroatom (alcohols, thiols, and amines) nucleophiles on the *N*-acyliminium ion forms a C--C bond or a C--X (O, S, and N) bond, followed by the deprotonation of the intermediate, affording the desired 3-substituted isoindolinones.

![Possible Reaction Pathways](ao9b02853_0006){#sch3}

Conclusions {#sec3}
===========

In summary, we have developed an efficient and practical method for the synthesis of 3-substituted isoindolinones involving various γ-hydroxy lactams and nucleophiles through the amidoalkylation reaction promoted by Ni(ClO~4~)~2~·6H~2~O. The transformation proceeds with C/O/S/N nucleophiles in the intermolecular and intramolecular manners. Furthermore, the method offers several advantages such as a wide variety of substrates, excellent group tolerability, easy handling, and good yields (up to 96% yield). Moreover, the 3-substituted isoindolinones products could be prepared on a gram scale.

Experimental Section {#sec4}
====================

General Details {#sec4.1}
---------------

Unless otherwise noted, all of the reagents were obtained commercially and used without further purification and reactions were monitored by thin-layer chromatography (TLC) using an ethyl acetate/petroleum ether (60--90 °C boiling mixture) mixture as the eluent. Column chromatography was performed on silica gel (200--300 mesh) using different percentages of ethyl acetate in petroleum ether. ^1^H NMR (400 MHz) and ^13^C NMR (100 MHz) spectra were recorded in CDCl~3~ on a Bruker 400 MHz spectrometer with tetramethylsilane (TMS) as an internal standard. High-resolution mass spectra (HRMS) were recorded on the Q-TOF6510 instruments.

Synthesis of Isoindoline-1,3-dione Derivatives {#sec4.2}
----------------------------------------------

In a 100 mL round-bottom flask, phthalic anhydride (7.4 g, 50 mmol) and the corresponding amine (50 mmol) were added to 50 mL of acetic acid, and the mixture was refluxed at 120 °C for 10 h. After completion of the reaction, water (100 mL) was added to the reaction mixture and the solution was extracted with CH~2~Cl~2~ (50 mL × 3). The combined organic layer was dried with anhydrous Na~2~SO~4~ and evaporated under reduced pressure. The residue was purified through column chromatography to afford the product isoindoline-1,3-dione derivatives.

Synthesis of γ-Hydroxy Lactam Derivatives {#sec4.3}
-----------------------------------------

A 25 mL round-bottom flask was charged with isoindoline-1,3-dione derivatives (2 mmol), methanol (10 mL), and a stirring bar. The flask was cooled to 0 °C. Then, sodium borohydride (370 mg, 10 mmol) was added portionwise over 5 min. The reaction mixture was stirred for 3 h. The conversion was measured by TLC (ethyl acetate/petroleum ether). If all of the starting material was not consumed after 3 h, 5 additional equivalents of sodium borohydride were added every 30 min until full conversion was realized. Upon complete conversion of the isoindoline-1,3-dione derivatives, the methanol was removed under vacuum and the reaction mixture was poured into a saturated aqueous solution of sodium hydrogen carbonate (20 mL) and then extracted with ethyl acetate (10 mL × 3). The combined organic extracts were dried over anhydrous sodium sulfate and evaporated to leave the hydroxy lactams, which were then purified by column on silica gel using a mixture of ethyl acetate/petroleum ether as the eluent to furnish the γ-hydroxy lactam derivatives.

General Procedure for the Nickel-Catalyzed Amidoalkylation Reaction of γ-Hydroxy Lactams {#sec4.4}
----------------------------------------------------------------------------------------

A 35 mL sealed tube was charged with γ-hydroxy lactams (0.2 mmol), different nucleophiles (0.24 mol), and Ni(ClO~4~)~2~·6H~2~O (0.02 mol), and then 1,2-dichloroethane (DCE, 2 mL) was added. The resulting reaction mixture was kept at 100 °C for 8 h while it was periodically checked by TLC for completion of the reaction. The reaction mixture was cooled to room temperature and then extracted with dichloromethane (DCM, 2 × 10 mL). The organic layer was washed successively with water (2 × 10 mL) and brine (1 × 10 mL), followed by the removal of DCM under reduced pressure. The crude product was subjected to column chromatography (silica gel, gradient elution with different percentages of EtOAc in petroleum ether) to yield 3-substituted isoindolinones.

### 2-Benzyl-3-(2-oxo-2-phenylethyl)isoindolin-1-one (**3a**)^[@cit13a]^ {#sec4.4.1}

White solid (62.7 mg, 92%), mp = 97--98 °C. ^1^H NMR (400 MHz, CDCl~3~) δ 7.95--7.85 (m, 1H), 7.79 (d, *J* = 7.3 Hz, 2H), 7.55 (t, *J* = 7.4 Hz, 1H), 7.51--7.44 (m, 2H), 7.40 (dd, *J* = 14.5, 6.8 Hz, 3H), 7.20 (ddt, *J* = 13.9, 9.6, 6.9 Hz, 5H), 5.31--5.18 (m, 1H), 5.06 (d, *J* = 15.4 Hz, 1H), 4.53 (d, *J* = 15.4 Hz, 1H), 3.49 (dd, *J* = 17.6, 5.3 Hz, 1H), 3.14 (dd, *J* = 17.6, 7.2 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~) δ 197.09, 168.55, 145.90, 137.16, 136.30, 133.67, 131.84, 131.78, 128.71, 128.46, 128.05, 128.03, 128.00, 127.97, 127.52, 123.89, 122.88, 55.92, 44.66, 42.10. HRMS \[electrospray ionization (ESI)\] calcd for C~23~H~20~NO~2~ \[M + H\]^+^ 342.1489, found 342.1490.

### 2-Benzyl-3-(2-(4-nitrophenyl)-2-oxoethyl)isoindolin-1-one (**3b**)^[@ref25]^ {#sec4.4.2}

White solid (73.3 mg, 95%), mp = 158--160 °C. ^1^H NMR (400 MHz, CDCl~3~) δ 8.22 (d, *J* = 8.8 Hz, 2H), 7.93 (dd, *J* = 5.7, 2.5 Hz, 1H), 7.86 (d, *J* = 8.8 Hz, 2H), 7.60--7.45 (m, 2H), 7.44--7.35 (m, 1H), 7.16 (ddd, *J* = 24.9, 14.2, 7.1 Hz, 5H), 5.28 (t, *J* = 6.0 Hz, 1H), 4.88 (d, *J* = 15.5 Hz, 1H), 4.74 (d, *J* = 15.5 Hz, 1H), 3.47 (dd, *J* = 17.9, 5.9 Hz, 1H), 3.19 (dd, *J* = 17.9, 6.2 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~) δ 195.57, 168.54, 150.51, 145.32, 140.43, 137.11, 131.99, 131.78, 129.01, 128.77, 128.72, 127.90, 127.54, 124.11, 123.80, 122.51, 55.88, 45.00, 42.90. HRMS (ESI) calcd for C~23~H~19~N~2~O~4~ \[M + H\]^+^ 387.1339, found 387.1340.

### 4-(2-(2-Benzyl-3-oxoisoindolin-1-yl)acetyl)benzonitrile (**3c**) {#sec4.4.3}

White solid (70.3 mg, 96%), mp = 180--182 °C. ^1^H NMR (400 MHz, CDCl~3~) δ 7.92 (dd, *J* = 5.5, 2.8 Hz, 1H), 7.80 (d, *J* = 8.4 Hz, 2H), 7.69 (d, *J* = 8.3 Hz, 2H), 7.57--7.45 (m, 2H), 7.41--7.31 (m, 1H), 7.24--7.02 (m, 5H), 5.26 (t, *J* = 6.0 Hz, 1H), 4.89 (d, *J* = 15.5 Hz, 1H), 4.70 (d, *J* = 15.5 Hz, 1H), 3.45 (dd, *J* = 17.9, 5.8 Hz, 1H), 3.15 (dd, *J* = 17.9, 6.4 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~) δ 195.77, 168.53, 145.37, 138.98, 137.09, 132.46, 131.97, 131.76, 128.71, 128.37, 127.89, 127.53, 124.06, 122.55, 117.70, 116.80, 55.85, 44.94, 42.61. HRMS (ESI) calcd for C~24~H~19~N~2~O~2~ \[M + H\]^+^ 367.1441, found 367.1440.

### 2-Benzyl-3-(2-oxo-2-(4-(trifluoromethyl)phenyl)ethyl)isoindolin-1-one (**3d**) {#sec4.4.4}

White solid (77.7 mg, 95%), mp = 162--163 °C. ^1^H NMR (400 MHz, CDCl~3~) δ 7.91 (dd, *J* = 5.6, 2.6 Hz, 1H), 7.84 (d, *J* = 8.1 Hz, 2H), 7.66 (d, *J* = 8.2 Hz, 2H), 7.54--7.44 (m, 2H), 7.41--7.35 (m, 1H), 7.25--7.15 (m, 4H), 7.12 (t, *J* = 7.0 Hz, 1H), 5.26 (t, *J* = 6.1 Hz, 1H), 4.94 (d, *J* = 15.5 Hz, 1H), 4.66 (d, *J* = 15.5 Hz, 1H), 3.48 (dd, *J* = 17.8, 5.6 Hz, 1H), 3.17 (dd, *J* = 17.8, 6.6 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~) δ 196.15, 168.54, 145.55, 138.78, 137.10, 134.81 (q, *J* = 32.5 Hz), 131.93, 131.78, 128.61, 128.12 (q, *J* = 370 Hz), 125.70 (q, *J* = 3.5 Hz), 124.00, 122.65, 122.09, 55.89, 44.86, 42.53. HRMS (ESI) calcd for C~24~H~19~F~3~NO~2~ \[M + H\]^+^ 410.1362, found 410.1363.

### 2-Benzyl-3-(2-(2-nitrophenyl)-2-oxoethyl)isoindolin-1-one (**3e**) {#sec4.4.5}

White solid (71.8 mg, 93%), mp = 145--147 °C. ^1^H NMR (400 MHz, CDCl~3~) δ 8.18--7.97 (m, 1H), 7.95--7.79 (m, 1H), 7.66--7.41 (m, 5H), 7.37--7.20 (m, 5H), 6.83 (dd, *J* = 7.1, 1.7 Hz, 1H), 5.11 (dd, *J* = 16.1, 10.6 Hz, 2H), 4.55 (d, *J* = 15.4 Hz, 1H), 3.28 (ddd, *J* = 24.7, 18.3, 5.5 Hz, 2H). ^13^C NMR (100 MHz, CDCl~3~) δ 199.01, 168.56, 145.53, 145.11, 137.33, 136.78, 134.32, 132.01, 131.77, 130.92, 128.86, 128.60, 128.12, 127.64, 127.27, 124.45, 123.88, 122.85, 55.37, 45.55, 44.69. HRMS (ESI) calcd for C~23~H~19~N~2~O~4~ \[M + H\]^+^ 387.1339, found 387.1336.

### 2-Benzyl-3-(2-(4-fluorophenyl)-2-oxoethyl)isoindolin-1-one (**3f**) {#sec4.4.6}

White solid (67.0 mg, 93%), mp = 152--154 °C. ^1^H NMR (400 MHz, CDCl~3~) δ 7.90 (dd, *J* = 5.3, 3.0 Hz, 1H), 7.79 (dd, *J* = 8.7, 5.4 Hz, 2H), 7.47 (dd, *J* = 9.0, 5.5 Hz, 2H), 7.43--7.34 (m, 1H), 7.28--7.11 (m, 5H), 7.07 (t, *J* = 8.6 Hz, 2H), 5.24 (t, *J* = 6.2 Hz, 1H), 4.99 (d, *J* = 15.4 Hz, 1H), 4.59 (d, *J* = 15.4 Hz, 1H), 3.43 (dd, *J* = 17.6, 5.5 Hz, 1H), 3.11 (dd, *J* = 17.6, 6.9 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~) δ 195.43, 168.54, 166.00 (d, *J* = 255 Hz), 167.27, 164.72, 145.77, 137.16, 132.74 (d, *J* = 3.0 Hz), 131.86, 131.77, 130.78, 130.68, 128.59 (d, *J* = 17.1 Hz), 127.94, 127.50, 123.92, 122.77, 115.93, 115.71, 55.96, 44.75, 42.09. HRMS (ESI) calcd for C~23~H~19~FNO~2~ \[M + H\]^+^ 360.1394, found 360.1395.

### 2-Benzyl-3-(2-(2-chlorophenyl)-2-oxoethyl)isoindolin-1-one (**3g**) {#sec4.4.7}

White solid (69.8 mg, 93%), mp = 132--134 °C. ^1^H NMR (400 MHz, CDCl~3~) δ 7.88 (d, *J* = 6.7 Hz, 1H), 7.55--7.39 (m, 3H), 7.34 (t, *J* = 6.7 Hz, 2H), 7.32--7.18 (m, 7H), 5.26--4.99 (m, 2H), 4.50 (d, *J* = 15.4 Hz, 1H), 3.57 (dd, *J* = 17.7, 4.9 Hz, 1H), 3.22 (dd, *J* = 17.7, 7.1 Hz, 1H). ^13^C NMR (126 MHz, CDCl~3~) δ 199.64, 168.49, 145.36, 138.14, 137.16, 132.40, 131.84, 131.80, 131.12, 130.73, 129.23, 128.81, 128.53, 127.95, 127.61, 127.05, 123.90, 122.78, 55.82, 45.95, 44.60. HRMS (ESI) calcd for C~23~H~19~ClNO~2~ \[M + H\]^+^ 376.1099, found 376.1097.

### 2-Benzyl-3-(2-(4-bromophenyl)-2-oxoethyl)isoindolin-1-one (**3h**)^[@ref26]^ {#sec4.4.8}

White solid (75.2 mg, 90%), mp = 137--138 °C. ^1^H NMR (400 MHz, CDCl~3~) δ 7.97--7.81 (m, 1H), 7.61 (d, *J* = 8.5 Hz, 2H), 7.57--7.50 (m, 2H), 7.47 (dd, *J* = 8.9, 5.3 Hz, 2H), 7.40--7.32 (m, 1H), 7.25--7.04 (m, 5H), 5.23 (t, *J* = 6.1 Hz, 1H), 4.98 (d, *J* = 15.4 Hz, 1H), 4.59 (d, *J* = 15.4 Hz, 1H), 3.42 (dd, *J* = 17.6, 5.5 Hz, 1H), 3.10 (dd, *J* = 17.6, 6.9 Hz, 1H). ^13^C NMR (126 MHz, CDCl~3~) δ 196.06, 168.52, 145.69, 137.14, 134.97, 131.99, 131.88, 131.77, 129.51, 128.91, 128.71, 128.54, 127.93, 127.52, 123.94, 122.74, 55.91, 44.77, 42.13. HRMS (ESI) calcd for C~23~H~19~BrNO~2~ \[M + H\]^+^ 420.0594, found 420.0595.

### 2-Benzyl-3-(2-(4-methoxyphenyl)-2-oxoethyl)isoindolin-1-one (**3i**)^[@ref26]^ {#sec4.4.9}

Yellow oil (63.1 mg, 85%). ^1^H NMR (400 MHz, CDCl~3~) δ 7.96--7.84 (m, 1H), 7.78 (d, *J* = 8.9 Hz, 2H), 7.45 (dd, *J* = 8.8, 5.1 Hz, 2H), 7.42--7.34 (m, 1H), 7.28--7.08 (m, 5H), 6.88 (d, *J* = 8.9 Hz, 2H), 5.23 (dd, *J* = 6.8, 5.7 Hz, 1H), 5.07 (d, *J* = 15.4 Hz, 1H), 4.50 (d, *J* = 15.4 Hz, 1H), 3.85 (s, 3H), 3.43 (dd, *J* = 17.3, 5.3 Hz, 1H), 3.09 (dd, *J* = 17.3, 7.4 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~) δ 195.48, 168.55, 163.94, 146.03, 137.21, 131.79, 131.77, 130.41, 129.47, 128.67, 128.38, 127.99, 127.49, 123.82, 122.95, 113.87, 56.07, 55.55, 44.60, 41.67. HRMS (ESI) calcd for C~24~H~22~NO~3~ \[M + H\]^+^ 372.1594, found 372.1594.

### 2-Benzyl-3-(2-(naphthalen-2-yl)-2-oxoethyl)isoindolin-1-one (**3j**) {#sec4.4.10}

White solid (68.0 mg, 87%), mp = 172--174 °C. ^1^H NMR (400 MHz, CDCl~3~) δ 8.67 (d, *J* = 8.6 Hz, 1H), 7.94 (d, *J* = 8.2 Hz, 1H), 7.92--7.87 (m, 1H), 7.85 (d, *J* = 8.0 Hz, 1H), 7.61 (dd, *J* = 11.2, 4.1 Hz, 1H), 7.52 (dd, *J* = 18.0, 7.6 Hz, 2H), 7.46--7.38 (m, 3H), 7.34 (t, *J* = 7.7 Hz, 1H), 7.28 (d, *J* = 6.5 Hz, 2H), 7.21 (q, *J* = 7.3 Hz, 3H), 5.34--5.22 (m, 1H), 5.12 (d, *J* = 15.4 Hz, 1H), 4.55 (d, *J* = 15.4 Hz, 1H), 3.59 (dd, *J* = 17.3, 5.3 Hz, 1H), 3.24 (dd, *J* = 17.3, 7.1 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~) δ 200.56, 168.58, 145.75, 137.26, 134.52, 133.97, 133.60, 131.85, 130.07, 128.80, 128.62, 128.49, 128.47, 128.41, 128.00, 127.58, 126.69, 125.60, 124.26, 123.94, 122.80, 56.28, 45.05, 44.70. HRMS (ESI) calcd for C~27~H~22~NO~2~ \[M + H\]^+^ 392.1645, found 392.1645.

### 2-Benzyl-3-(2-(3,4-dimethylphenyl)-2-oxoethyl)isoindolin-1-one (**3k**) {#sec4.4.11}

White solid (63.5 mg, 86%), mp = 135--137 °C. ^1^H NMR (400 MHz, CDCl~3~) δ 7.97--7.73 (m, 1H), 7.59 (s, 1H), 7.53 (d, *J* = 7.9 Hz, 1H), 7.45 (dd, *J* = 8.7, 5.1 Hz, 2H), 7.41--7.36 (m, 1H), 7.24 (q, *J* = 7.3 Hz, 4H), 7.17 (dd, *J* = 10.4, 7.4 Hz, 2H), 5.22 (dd, *J* = 7.1, 5.5 Hz, 1H), 5.10 (d, *J* = 15.3 Hz, 1H), 4.48 (d, *J* = 15.3 Hz, 1H), 3.48 (dd, *J* = 17.4, 5.2 Hz, 1H), 3.11 (dd, *J* = 17.4, 7.4 Hz, 1H), 2.30 (s, 3H), 2.27 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 196.97, 168.54, 146.04, 143.37, 137.23, 137.12, 134.34, 131.78, 129.94, 129.20, 128.69, 128.38, 128.06, 128.01, 127.96, 127.50, 125.82, 123.83, 122.97, 55.99, 44.57, 41.95, 20.07, 19.75. HRMS (ESI) calcd for C~25~H~24~NO~2~ \[M + H\]^+^ 370.1802, found 370.1803.

### 2-Isopropyl-3-(2-(4-nitrophenyl)-2-oxoethyl)isoindolin-1-one (**3l**) {#sec4.4.12}

White solid (55.4 mg, 82%), mp = 142--144 °C. ^1^H NMR (400 MHz, CDCl~3~) δ 8.32 (d, *J* = 8.8 Hz, 2H), 8.13 (d, *J* = 8.8 Hz, 2H), 7.87--7.70 (m, 1H), 7.48--7.38 (m, 2H), 7.38--7.30 (m, 1H), 5.36 (dd, *J* = 8.6, 3.5 Hz, 1H), 4.24 (dt, *J* = 13.8, 6.9 Hz, 1H), 3.72 (dd, *J* = 17.9, 3.6 Hz, 1H), 3.38 (dd, *J* = 17.9, 8.7 Hz, 1H), 1.50 (d, *J* = 6.8 Hz, 3H), 1.45 (d, *J* = 6.8 Hz, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 196.17, 168.33, 150.65, 145.67, 140.75, 132.63, 131.63, 129.23, 128.53, 124.07, 123.47, 122.53, 55.65, 45.55, 43.72, 21.19, 20.53. HRMS (ESI) calcd for C~19~H~19~N~2~O~4~ \[M + H\]^+^ 339.1339, found 339.1339.

### 3-(2-(4-Nitrophenyl)-2-oxoethyl)-2-phenylisoindolin-1-one (**3m**) {#sec4.4.13}

White solid (64.7 mg, 87%), mp = 153--155 °C. ^1^H NMR (400 MHz, CDCl~3~) δ 8.26 (d, *J* = 8.8 Hz, 2H), 7.97 (dd, *J* = 13.0, 5.2 Hz, 3H), 7.81--7.34 (m, 7H), 7.23 (t, *J* = 7.4 Hz, 1H), 5.97 (dd, *J* = 9.1, 3.0 Hz, 1H), 3.58 (dd, *J* = 17.9, 3.2 Hz, 1H), 3.26 (dd, *J* = 17.9, 9.1 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~) δ 196.32, 166.79, 150.64, 144.67, 140.55, 136.47, 132.51, 131.89, 129.46, 129.14, 129.03, 125.89, 124.40, 123.94, 123.35, 122.93, 56.79, 42.57. HRMS (ESI) calcd for C~22~H~17~N~2~O~4~ \[M + H\]^+^ 373.1183, found 373.1185.

### 3-(2-(4-Nitrophenyl)-2-oxoethyl)-2-(*p*-tolyl)isoindolin-1-one (**3n**) {#sec4.4.14}

White solid (64.8 mg, 84%), mp = 161--162 °C. ^1^H NMR (400 MHz, CDCl~3~) δ 8.24 (d, *J* = 8.8 Hz, 2H), 7.95 (dd, *J* = 18.9, 7.6 Hz, 3H), 7.57--7.40 (m, 5H), 7.22 (d, *J* = 8.1 Hz, 2H), 5.90 (dd, *J* = 9.0, 3.1 Hz, 1H), 3.56 (dd, *J* = 17.8, 3.3 Hz, 1H), 3.24 (dd, *J* = 17.8, 9.1 Hz, 1H), 2.33 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 196.38, 166.74, 150.58, 144.70, 140.58, 135.87, 133.79, 132.35, 131.99, 130.01, 129.15, 128.95, 124.27, 123.89, 123.58, 122.93, 57.01, 42.54, 20.97. HRMS (ESI) calcd for C~23~H~19~N~2~O~4~ \[M + H\]^+^ 387.1339, found 387.1340.

### 2-(4-Chlorobenzyl)-3-(2-(4-nitrophenyl)-2-oxoethyl)isoindolin-1-one (**3o**) {#sec4.4.15}

White solid (71.4 mg, 85%), mp = 165--166 °C. ^1^H NMR (400 MHz, CDCl~3~) δ 8.25 (d, *J* = 8.7 Hz, 2H), 7.93 (d, *J* = 6.7 Hz, 1H), 7.86 (d, *J* = 8.7 Hz, 2H), 7.61--7.46 (m, 2H), 7.39 (d, *J* = 7.1 Hz, 1H), 7.12 (q, *J* = 8.4 Hz, 4H), 5.30 (t, *J* = 5.9 Hz, 1H), 4.76 (s, 2H), 3.41 (dd, *J* = 17.9, 6.5 Hz, 1H), 3.22 (dd, *J* = 17.9, 5.4 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~) δ 195.39, 168.66, 150.60, 145.24, 140.13, 135.71, 133.44, 132.17, 131.58, 129.31, 128.98, 128.83, 124.20, 123.86, 122.40, 55.96, 44.55, 43.11. HRMS (ESI) calcd for C~23~H~18~ClN~2~O~4~ \[M + H\]^+^ 421.0950, found 421.0952.

### 2-(4-Fluorobenzyl)-3-(2-(4-nitrophenyl)-2-oxoethyl)isoindolin-1-one (**3p**) {#sec4.4.16}

White solid (67.1 mg, 82%), mp = 171--173 °C. ^1^H NMR (400 MHz, CDCl~3~) δ 8.26 (d, *J* = 8.8 Hz, 2H), 8.00--7.81 (m, 3H), 7.59--7.45 (m, 2H), 7.38 (d, *J* = 7.3 Hz, 1H), 7.21 (dd, *J* = 8.3, 5.5 Hz, 2H), 6.87 (t, *J* = 8.6 Hz, 2H), 5.27 (t, *J* = 6.0 Hz, 1H), 4.88 (d, *J* = 15.4 Hz, 1H), 4.65 (d, *J* = 15.4 Hz, 1H), 3.45 (dd, *J* = 18.0, 6.1 Hz, 1H), 3.24 (dd, *J* = 18.0, 6.0 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~) δ 195.52, 168.58, 161.643 (d, *J* = 245 Hz), 150.61, 145.28, 140.32, 132.94 (d, *J* = 3.1 Hz), 132.11, 131.65, 129.63 (d, *J* = 8.0 Hz), 129.02, 128.79, 124.14, 123.89, 122.49, 115.69, 115.47, 55.74, 44.29, 42.99. HRMS (ESI) calcd for C~23~H~18~FN~2~O~4~ \[M + H\]^+^ 405.1245, found 4051245.

### 2-(4-Methylbenzyl)-3-(2-(4-nitrophenyl)-2-oxoethyl)isoindolin-1-one (**3q**) {#sec4.4.17}

White solid (69.6 mg, 87%), mp = 163--165 °C. ^1^H NMR (400 MHz, CDCl~3~) δ 8.22 (d, *J* = 8.7 Hz, 2H), 7.93 (dd, *J* = 5.4, 2.9 Hz, 1H), 7.85 (d, *J* = 8.7 Hz, 2H), 7.57--7.46 (m, 2H), 7.43--7.33 (m, 1H), 7.09 (d, *J* = 7.8 Hz, 2H), 6.96 (d, *J* = 7.8 Hz, 2H), 5.26 (t, *J* = 6.0 Hz, 1H), 4.82 (d, *J* = 15.4 Hz, 1H), 4.70 (d, *J* = 15.4 Hz, 1H), 3.47 (dd, *J* = 17.8, 5.9 Hz, 1H), 3.16 (dd, *J* = 17.8, 6.2 Hz, 1H), 2.18 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 195.52, 168.50, 150.47, 145.32, 140.39, 137.25, 133.94, 131.93, 131.86, 129.36, 129.04, 128.69, 127.93, 124.10, 123.71, 122.45, 55.86, 44.76, 42.83, 20.95. HRMS (ESI) calcd for C~24~H~21~N~2~O~4~ \[M + H\]^+^ 401.1496, found 401.1497.

### 2-(4-Chlorophenethyl)-3-(2-(4-nitrophenyl)-2-oxoethyl)isoindolin-1-one (**3r**) {#sec4.4.18}

White solid (76.4 mg, 88%), mp = 132--134 °C. ^1^H NMR (400 MHz, CDCl~3~) δ 8.32 (d, *J* = 8.8 Hz, 2H), 8.01 (d, *J* = 8.8 Hz, 2H), 7.85 (d, *J* = 6.7 Hz, 1H), 7.49 (tt, *J* = 13.0, 6.7 Hz, 2H), 7.37 (d, *J* = 7.2 Hz, 1H), 7.18 (q, *J* = 8.4 Hz, 4H), 5.21 (t, *J* = 6.0 Hz, 1H), 4.10--3.94 (m, 1H), 3.56--3.40 (m, 1H), 3.22--2.93 (m, 4H). ^13^C NMR (100 MHz, CDCl~3~) δ 195.88, 168.57, 150.70, 145.28, 140.35, 137.54, 132.42, 131.92, 130.46, 129.18, 128.75, 128.70, 124.09, 123.74, 122.60, 55.79, 43.15, 42.88, 33.75. HRMS (ESI) calcd for C~24~H~20~ClN~2~O~4~ \[M + H\]^+^ 435.1106, found 435.1105.

### 2-Benzyl-3-(2,4,6-trimethoxyphenyl)isoindolin-1-one (**5a**)^[@ref21]^ {#sec4.4.19}

White solid (71.6 mg, 92%), mp = 102--104 °C. ^1^H NMR (400 MHz, CDCl~3~) δ 7.88 (dd, *J* = 5.1, 3.4 Hz, 1H), 7.44--7.31 (m, 2H), 7.25--6.99 (m, 6H), 6.16 (d, *J* = 2.0 Hz, 1H), 5.99 (s, 1H), 5.92 (d, *J* = 2.0 Hz, 1H), 5.14 (d, *J* = 14.7 Hz, 1H), 3.83 (d, *J* = 14.8 Hz, 1H), 3.80 (s, 3H), 3.70 (s, 3H), 3.25 (s, 3H). ^13^C NMR (126 MHz, CDCl~3~) δ 168.91, 161.69, 160.50, 160.14, 146.98, 137.91, 132.95, 130.86, 128.56, 128.12, 127.10, 126.99, 122.96, 121.83, 103.99, 91.24, 90.44, 55.79, 55.41, 55.32, 54.73, 44.15. HRMS (ESI) calcd for C~24~H~24~NO~4~ \[M + H\]^+^ 390.1700, found 390.1700.

### 2-Benzyl-3-mesitylisoindolin-1-one (**5b**) {#sec4.4.20}

White solid (61.4 mg, 90%), mp = 132--134 °C. ^1^H NMR (400 MHz, CDCl~3~) δ 8.04--7.85 (m, 1H), 7.53--7.36 (m, 2H), 7.26 (q, *J* = 6.0 Hz, 3H), 7.16--7.03 (m, 3H), 6.90 (s, 1H), 6.73 (s, 1H), 5.75 (s, 1H), 5.44 (d, *J* = 14.6 Hz, 1H), 3.60 (d, *J* = 14.7 Hz, 1H), 2.28 (s, 3H), 2.04 (s, 3H), 1.57 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 168.58, 145.15, 138.12, 138.08, 138.03, 137.24, 132.59, 131.80, 131.44, 129.68, 128.68, 128.52, 128.22, 128.01, 127.58, 123.67, 122.37, 59.29, 43.79, 20.89, 20.61, 18.53. HRMS (ESI) calcd for C~24~H~24~NO \[M + H\]^+^ 342.1852, found 342.1853.

### 2-Benzyl-3-(5-methylthiophen-2-yl)isoindolin-1-one (**5c**)^[@ref21]^ {#sec4.4.21}

White solid (58.3 mg, 91%), mp = 206--207 °C. ^1^H NMR (400 MHz, CDCl~3~) δ 7.91 (dd, *J* = 5.7, 2.8 Hz, 1H), 7.53--7.39 (m, 2H), 7.27 (dt, *J* = 12.0, 7.2 Hz, 6H), 6.83 (d, *J* = 3.3 Hz, 1H), 6.72--6.33 (m, 1H), 5.47 (s, 1H), 5.38 (d, *J* = 14.9 Hz, 1H), 3.90 (d, *J* = 14.9 Hz, 1H), 2.42 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.77, 145.78, 141.60, 137.51, 137.21, 131.91, 131.25, 128.74, 128.65, 128.55, 128.50, 127.92, 127.58, 124.89, 123.74, 123.25, 59.07, 43.61, 15.54. HRMS (ESI) calcd for C~20~H~18~NOS \[M + H\]^+^ 320.1104, found 320.1105.

### 5,12b-Dihydroisoindolo\[1,2-*a*\]isoquinolin-8(6*H*)-one (**6a**)^[@ref27]^ {#sec4.4.22}

White solid (41.8 mg, 89%), mp = 114--116 °C. ^1^H NMR (400 MHz, CDCl~3~) δ 7.87 (dd, *J* = 7.5, 2.7 Hz, 2H), 7.68--7.56 (m, 2H), 7.49 (t, *J* = 7.5 Hz, 1H), 7.33--7.15 (m, 3H), 5.67 (s, 1H), 4.43 (dt, *J* = 12.7, 5.2 Hz, 1H), 3.59--3.38 (m, 1H), 3.07 (ddd, *J* = 15.5, 9.1, 6.1 Hz, 1H), 2.88 (dt, *J* = 15.9, 4.5 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.94, 144.25, 134.82, 134.37, 132.87, 131.52, 129.32, 128.50, 127.46, 126.72, 125.24, 123.88, 123.49, 59.15, 38.21, 29.45. HRMS (ESI) calcd for C~16~H~14~NO \[M + H\]^+^ 236.1070, found 236.1070.

### 2-Methyl-5,12b-dihydroisoindolo\[1,2-*a*\]isoquinolin-8(6*H*)-one (**6b**) {#sec4.4.23}

White solid (45.3 mg, 91%), mp = 102--103 °C. ^1^H NMR (400 MHz, CDCl~3~) δ 7.88 (dd, *J* = 7.5, 3.6 Hz, 2H), 7.62 (t, *J* = 7.5 Hz, 1H), 7.50 (t, *J* = 7.5 Hz, 1H), 7.42 (s, 1H), 7.07 (dd, *J* = 18.1, 7.7 Hz, 2H), 5.64 (s, 1H), 4.45--4.37 (m, 1H), 3.51--3.41 (m, 1H), 3.01 (dd, *J* = 9.1, 6.4 Hz, 1H), 2.88--2.79 (m, 1H), 2.37 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.96, 144.30, 136.35, 134.18, 132.87, 131.72, 131.49, 129.16, 128.46, 128.26, 125.77, 123.87, 123.50, 59.19, 38.37, 29.06, 21.26. HRMS (ESI) calcd for C~17~H~16~NO \[M + H\]^+^ 250.1226, found 250.1226.

### 2-Methoxy-5,12b-dihydroisoindolo\[1,2-*a*\]isoquinolin-8(6*H*)-one (**6c**)^[@ref28]^ {#sec4.4.24}

White solid (46.1 mg, 87%), mp = 102--103 °C. ^1^H NMR (400 MHz, CDCl~3~) δ 7.87 (t, *J* = 7.9 Hz, 2H), 7.61 (t, *J* = 7.5 Hz, 1H), 7.50 (t, *J* = 7.5 Hz, 1H), 7.14 (dd, *J* = 15.6, 5.1 Hz, 2H), 6.80 (dd, *J* = 8.3, 2.2 Hz, 1H), 5.64 (s, 1H), 4.41 (dt, *J* = 12.6, 5.1 Hz, 1H), 3.82 (s, 3H), 3.53--3.41 (m, 1H), 3.01 (ddd, *J* = 15.3, 9.2, 6.0 Hz, 1H), 2.83 (dt, *J* = 15.5, 4.5 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.94, 158.32, 144.09, 135.40, 132.89, 131.55, 130.12, 128.53, 126.84, 123.91, 123.39, 112.55, 111.47, 59.23, 55.43, 38.48, 28.58. HRMS (ESI) calcd for C~17~H~16~NO~2~ \[M + H\]^+^ 266.1176, found 266.1176.

### 5-Phenyl-5,12b-dihydroisoindolo\[1,2-*a*\]isoquinolin-8(6*H*)-one (**6d**) {#sec4.4.25}

White solid (51.0 mg, 82%), mp = 178--180 °C. ^1^H NMR (400 MHz, CDCl~3~) δ 7.90 (t, *J* = 7.3 Hz, 2H), 7.74 (d, *J* = 7.8 Hz, 1H), 7.60 (t, *J* = 7.5 Hz, 1H), 7.48 (t, *J* = 7.5 Hz, 1H), 7.39--7.18 (m, 6H), 7.11 (t, *J* = 7.5 Hz, 1H), 6.85 (d, *J* = 7.8 Hz, 1H), 5.83 (s, 1H), 4.74 (dd, *J* = 13.2, 5.9 Hz, 1H), 4.25 (dd, *J* = 10.5, 6.0 Hz, 1H), 3.47 (dd, *J* = 13.0, 10.9 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.80, 144.94, 141.60, 138.22, 134.39, 132.62, 131.80, 130.17, 129.10, 128.85, 128.58, 127.37, 127.24, 126.86, 125.42, 123.95, 123.46, 59.56, 45.79, 45.18. HRMS (ESI) calcd for C~16~H~13~ClNO \[M + H\]^+^ 270.0680, found 270.0681.

### 2-Benzyl-3-methoxyisoindolin-1-one (**8a**) {#sec4.4.26}

Colorless oil (46.6 mg, 92%). ^1^H NMR (400 MHz, CDCl~3~) δ 7.87 (d, *J* = 7.1 Hz, 1H), 7.60--7.45 (m, 3H), 7.40--7.21 (m, 5H), 5.71 (s, 1H), 5.19 (d, *J* = 14.7 Hz, 1H), 4.21 (d, *J* = 14.7 Hz, 1H), 2.88 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.48, 140.47, 136.87, 132.99, 132.10, 129.97, 128.72, 128.65, 128.63, 127.65, 123.68, 123.51, 85.64, 49.36, 43.15. HRMS (ESI) calcd for C~16~H~16~NO~2~ \[M + H\]^+^ 254.1176, found 254.1175.

### 2-Benzyl-3-ethoxyisoindolin-1-one (**8b**) {#sec4.4.27}

Colorless oil (47.5 mg, 89%). ^1^H NMR (400 MHz, CDCl~3~) δ 7.86 (d, *J* = 7.1 Hz, 1H), 7.60--7.45 (m, 3H), 7.31 (ddd, *J* = 22.6, 16.7, 6.9 Hz, 5H), 5.71 (s, 1H), 5.15 (d, *J* = 14.7 Hz, 1H), 4.27 (d, *J* = 14.7 Hz, 1H), 3.15 (dq, *J* = 14.2, 7.1 Hz, 1H), 2.99 (dd, *J* = 15.9, 7.1 Hz, 1H), 1.09 (t, *J* = 7.0 Hz, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.38, 141.19, 137.00, 132.76, 132.03, 129.83, 128.70, 128.62, 128.59, 127.62, 123.63, 123.40, 85.56, 58.03, 43.33, 15.05. HRMS (ESI) calcd for C~17~H~18~NO~2~ \[M + H\]^+^ 268.1332, found 268.1332.

### 2-Benzyl-3-butoxyisoindolin-1-one (**8c**) {#sec4.4.28}

Colorless oil (51.9 mg, 88%). ^1^H NMR (400 MHz, CDCl~3~) δ 7.86 (d, *J* = 7.1 Hz, 1H), 7.59--7.45 (m, 3H), 7.31 (ddd, *J* = 29.7, 15.5, 7.1 Hz, 5H), 5.71 (s, 1H), 5.17 (d, *J* = 14.7 Hz, 1H), 4.24 (d, *J* = 14.7 Hz, 1H), 3.09 (dd, *J* = 15.3, 6.5 Hz, 1H), 2.92 (dd, *J* = 15.3, 6.6 Hz, 1H), 1.45 (dq, *J* = 13.1, 6.5 Hz, 2H), 1.31 (dq, *J* = 15.1, 7.4 Hz, 2H), 0.86 (t, *J* = 7.3 Hz, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.38, 141.20, 136.98, 132.80, 132.01, 129.81, 128.70, 128.62, 127.61, 123.62, 123.40, 85.43, 62.14, 43.26, 31.63, 19.35, 13.84. HRMS (ESI) calcd for C~19~H~22~NO~2~ \[M + H\]^+^ 296.1645, found 296.1645.

### 2-Benzyl-3-(heptyloxy)isoindolin-1-one (**8d**) {#sec4.4.29}

Colorless oil (57.3 mg, 85%). ^1^H NMR (400 MHz, CDCl~3~) δ 7.85 (d, *J* = 7.1 Hz, 1H), 7.50 (ddd, *J* = 20.8, 13.7, 6.9 Hz, 3H), 7.37 (d, *J* = 7.2 Hz, 2H), 7.30 (t, *J* = 7.3 Hz, 2H), 7.26--7.22 (m, 1H), 5.70 (s, 1H), 5.16 (d, *J* = 14.7 Hz, 1H), 4.25 (d, *J* = 14.7 Hz, 1H), 3.08 (dd, *J* = 15.3, 6.6 Hz, 1H), 2.91 (dd, *J* = 15.4, 6.6 Hz, 1H), 1.45 (dd, *J* = 10.6, 6.1 Hz, 2H), 1.23 (s, 8H), 0.87 (t, *J* = 6.8 Hz, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.35, 141.24, 137.03, 132.81, 132.00, 129.80, 128.81--128.51, 127.61, 123.61, 123.41, 85.49, 62.45, 43.31, 31.78, 29.56, 29.05, 26.13, 22.61, 14.11. HRMS (ESI) calcd for C~22~H~28~NO~2~ \[M + H\]^+^ 338.2115, found 338.2115.

### 2-Benzyl-3-cyclobutoxyisoindolin-1-one (**8e**) {#sec4.4.30}

Colorless oil (52.2 mg, 89%). ^1^H NMR (400 MHz, CDCl~3~) δ 7.85 (d, *J* = 6.4 Hz, 1H), 7.56--7.44 (m, 3H), 7.29 (ddd, *J* = 22.7, 13.7, 7.0 Hz, 5H), 5.63 (s, 1H), 5.17 (d, *J* = 14.7 Hz, 1H), 4.22 (d, *J* = 14.8 Hz, 1H), 3.67 (dd, *J* = 15.1, 7.6 Hz, 1H), 2.00 (dd, *J* = 16.5, 8.2 Hz, 2H), 1.86 (dd, *J* = 19.1, 10.1 Hz, 1H), 1.59 (dtd, *J* = 15.3, 10.4, 6.2 Hz, 2H), 1.29--1.19 (m, 1H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.37, 141.80, 137.00, 132.53, 131.88, 129.80, 128.71, 128.58, 128.55, 127.61, 123.75, 123.51, 84.88, 67.47, 43.19, 32.45, 31.58, 12.84. HRMS (ESI) calcd for C~19~H~22~NO~2~ \[M + H\]^+^ 296.1645, found 296.1645.

### 2-Benzyl-3-(cyclopentyloxy)isoindolin-1-one (**8f**) {#sec4.4.31}

Colorless oil (53.4 mg, 87%). ^1^H NMR (400 MHz, CDCl~3~) δ 7.85 (d, *J* = 7.1 Hz, 1H), 7.51 (ddd, *J* = 17.5, 11.9, 7.1 Hz, 3H), 7.37--7.22 (m, 5H), 5.64 (s, 1H), 5.25 (d, *J* = 14.9 Hz, 1H), 4.24 (d, *J* = 14.9 Hz, 1H), 3.92--3.70 (m, 1H), 1.76--1.62 (m, 4H), 1.45 (ddt, *J* = 15.2, 12.3, 7.7 Hz, 4H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.41, 142.31, 137.08, 132.50, 131.93, 129.73, 128.74, 128.37, 128.35, 128.32, 127.59, 123.75, 123.56, 85.38, 77.06, 43.23, 33.72, 33.50, 23.32, 23.22. HRMS (ESI) calcd for C~20~H~22~NO~2~ \[M + H\]^+^ 308.1645, found 308.1645.

### 2-Benzyl-3-(isopentyloxy)isoindolin-1-one (**8g**) {#sec4.4.32}

Colorless oil (54.4 mg, 88%). ^1^H NMR (400 MHz, CDCl~3~) δ 7.86 (d, *J* = 7.2 Hz, 1H), 7.57--7.44 (m, 3H), 7.37 (d, *J* = 7.2 Hz, 2H), 7.31 (t, *J* = 7.3 Hz, 2H), 7.27--7.23 (m, 1H), 5.71 (s, 1H), 5.16 (d, *J* = 14.6 Hz, 1H), 4.26 (d, *J* = 14.7 Hz, 1H), 3.19--3.04 (m, 1H), 2.93 (dd, *J* = 15.7, 6.9 Hz, 1H), 1.64 (dt, *J* = 13.4, 6.7 Hz, 1H), 1.35 (ddt, *J* = 20.4, 13.7, 6.8 Hz, 2H), 0.82 (dd, *J* = 14.3, 6.6 Hz, 6H). ^13^C NMR (100 MHz, CDCl~3~) δ 141.21, 137.01, 132.79, 132.03, 129.83, 129.79, 128.71, 128.68, 128.61, 127.62, 123.62, 123.38, 85.51, 60.77, 43.33, 38.42, 24.90. HRMS (ESI) calcd for C~20~H~24~NO~2~ \[M + H\]^+^ 310.1802, found 310.1803.

### 2-Benzyl-3-(3-methoxypropoxy)isoindolin-1-one (**8h**) {#sec4.4.33}

Colorless oil (52.3 mg, 88%). ^1^H NMR (400 MHz, CDCl~3~) δ 7.86 (d, *J* = 7.2 Hz, 1H), 7.57--7.44 (m, 3H), 7.31 (ddd, *J* = 23.7, 17.1, 7.0 Hz, 5H), 5.70 (s, 1H), 5.17 (d, *J* = 14.7 Hz, 1H), 4.24 (d, *J* = 14.7 Hz, 1H), 3.39 (dt, *J* = 9.0, 4.6 Hz, 2H), 3.29 (s, 3H), 3.24--3.17 (m, 1H), 3.07--2.97 (m, 1H), 1.77--1.69 (m, 2H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.35, 141.08, 137.00, 132.76, 132.06, 129.87, 128.73, 128.63, 128.61, 127.71, 127.64, 123.65, 123.42, 85.43, 69.32, 59.47, 58.60, 43.23, 29.72. HRMS (ESI) calcd for C~19~H~22~NO~3~ \[M + H\]^+^ 312.1594, found 312.1594.

### 2-Benzyl-3-(benzyloxy)isoindolin-1-one (**8i**) {#sec4.4.34}

Colorless oil (55.6 mg, 90%). ^1^H NMR (400 MHz, CDCl~3~) δ 7.89 (d, *J* = 6.4 Hz, 1H), 7.55--7.45 (m, 3H), 7.36 (d, *J* = 7.1 Hz, 2H), 7.33--7.22 (m, 6H), 7.17 (d, *J* = 7.0 Hz, 2H), 5.84 (s, 1H), 5.16 (d, *J* = 14.7 Hz, 1H), 4.28 (d, *J* = 14.7 Hz, 1H), 4.10 (d, *J* = 11.2 Hz, 1H), 3.99 (d, *J* = 11.1 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.47, 140.93, 137.33, 136.94, 132.84, 132.26, 130.09, 128.81, 128.71, 128.52, 127.94, 127.88, 127.74, 123.77, 123.64, 85.67, 64.77, 43.52. HRMS (ESI) calcd for C~22~H~20~NO~2~ \[M + H\]^+^ 330.1489, found 330.1490.

### 2-Benzyl-3-phenethoxyisoindolin-1-one (**8j**) {#sec4.4.35}

Colorless oil (62.4 mg, 91%). ^1^H NMR (400 MHz, CDCl~3~) δ 7.88--7.79 (m, 1H), 7.52--7.44 (m, 2H), 7.34--7.19 (m, 9H), 7.12 (d, *J* = 7.2 Hz, 2H), 5.66 (s, 1H), 4.98 (d, *J* = 14.7 Hz, 1H), 3.87 (d, *J* = 14.7 Hz, 1H), 3.25 (dd, *J* = 15.7, 7.1 Hz, 1H), 3.18--3.07 (m, 1H), 2.72 (t, *J* = 6.5 Hz, 2H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.37, 140.83, 138.80, 137.00, 132.77, 132.05, 129.89, 129.11, 128.69, 128.62, 128.43, 127.60, 126.48, 123.66, 123.48, 85.39, 63.15, 43.03, 36.05. HRMS (ESI) calcd for C~23~H~22~NO~2~ \[M + H\]^+^ 344.4645, found 344.1645.

### 2-Benzyl-3-(*p*-tolyloxy)isoindolin-1-one (**8k**) {#sec4.4.36}

Colorless oil (61.7 mg, 90%). ^1^H NMR (400 MHz, CDCl~3~) δ 7.89 (d, *J* = 6.5 Hz, 1H), 7.59--7.47 (m, 3H), 7.36 (d, *J* = 7.0 Hz, 2H), 7.27 (dt, *J* = 20.3, 7.2 Hz, 3H), 7.10 (dd, *J* = 20.4, 7.9 Hz, 4H), 5.83 (s, 1H), 5.17 (d, *J* = 14.7 Hz, 1H), 4.27 (d, *J* = 14.7 Hz, 1H), 4.02 (dd, *J* = 42.6, 10.9 Hz, 2H), 2.32 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.47, 141.02, 137.70, 136.94, 134.25, 132.83, 132.22, 130.02, 129.20, 128.78, 128.71, 128.01, 127.70, 123.75, 123.62, 85.58, 64.75, 43.46, 21.23. HRMS (ESI) calcd for C~22~H~20~NO~2~ \[M + H\]^+^ 330.1489, found 330.1490.

### 3-(Benzhydryloxy)-2-benzylisoindolin-1-one (**8l**) {#sec4.4.37}

Colorless oil (73.7 mg, 91%). ^1^H NMR (400 MHz, CDCl~3~) δ 7.84 (d, *J* = 7.5 Hz, 1H), 7.41 (t, *J* = 7.5 Hz, 1H), 7.33--7.14 (m, 16H), 7.01 (d, *J* = 7.5 Hz, 1H), 5.84 (s, 1H), 5.29 (s, 1H), 5.04 (d, *J* = 15.1 Hz, 1H), 3.81 (d, *J* = 15.1 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.50, 142.40, 140.39, 141.43, 136.98, 132.45, 131.83, 129.81, 128.78, 128.73, 128.39, 128.32, 128.30, 127.87, 127.65, 127.43, 137.31, 126.71, 124.05, 123.46, 85.51, 78.93, 43.11. HRMS (ESI) calcd for C~28~H~24~NO~2~ \[M + H\]^+^ 406.1802, found 406.1803.

### 3-Ethoxy-2-(4-fluorobenzyl)isoindolin-1-one (**8m**) {#sec4.4.38}

Colorless oil (53.0 mg, 93%). ^1^H NMR (400 MHz, CDCl~3~) δ 7.86 (d, *J* = 7.3 Hz, 1H), 7.53 (ddd, *J* = 10.6, 10.0, 5.4 Hz, 3H), 7.37 (dd, *J* = 8.3, 5.5 Hz, 2H), 7.00 (t, *J* = 8.6 Hz, 2H), 5.71 (s, 1H), 5.07 (d, *J* = 14.7 Hz, 1H), 4.28 (d, *J* = 14.7 Hz, 1H), 3.19--3.05 (m, 1H), 3.04--2.92 (m, 1H), 1.09 (t, *J* = 7.0 Hz, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.35, 162.28 (d, *J* = 245 Hz), 141.08, 132.86 (d, *J* = 3.1 Hz), 132.64, 132.12, 130.39, 130.37, 130.34, 130.31, 129.89, 123.53 (d, *J* = 22 Hz), 123.42, 115.63, 115.42, 85.58, 57.96, 42.66, 15.01. HRMS (ESI) calcd for C~17~H~17~FNO~2~ \[M + H\]^+^ 286.1238, found 286.1239.

### 3-Ethoxy-2-(4-methylbenzyl)isoindolin-1-one (**8n**) {#sec4.4.39}

Colorless oil (48.9 mg, 87%). ^1^H NMR (400 MHz, CDCl~3~) δ 7.85 (d, *J* = 7.1 Hz, 1H), 7.52 (ddd, *J* = 19.0, 12.7, 6.8 Hz, 3H), 7.27 (d, *J* = 7.9 Hz, 2H), 7.12 (d, *J* = 7.8 Hz, 2H), 5.70 (s, 1H), 5.13 (d, *J* = 14.6 Hz, 1H), 4.20 (d, *J* = 14.6 Hz, 1H), 3.25--2.89 (m, 2H), 2.31 (s, 3H), 1.10 (t, *J* = 7.0 Hz, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.32, 141.22, 137.28, 133.95, 132.83, 131.97, 129.78, 129.35, 128.62, 123.58, 123.36, 85.43, 58.03, 43.00, 21.11, 15.09. HRMS (ESI) calcd for C~18~H~20~NO~2~ \[M + H\]^+^ 282.1489, found 282.1490.

### 3-Ethoxy-2-(*p*-tolyl)isoindolin-1-one (**8o**) {#sec4.4.40}

Colorless oil (45.4 mg, 85%). ^1^H NMR (400 MHz, CDCl~3~) δ 7.90 (d, *J* = 7.4 Hz, 1H), 7.73--7.48 (m, 5H), 6.98 (d, *J* = 9.0 Hz, 2H), 6.35 (s, 1H), 3.83 (s, 3H), 3.27 (dd, *J* = 8.8, 7.2 Hz, 1H), 3.03 (dd, *J* = 8.8, 7.2 Hz, 1H), 1.04 (t, *J* = 7.0 Hz, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 166.60, 157.32, 140.57, 132.81, 132.51, 130.35, 130.10, 124.00, 123.78, 123.30, 114.35, 87.64, 58.01, 55.47, 15.00. HRMS (ESI) calcd for C~17~H~18~NO~2~ \[M + H\]^+^ 268.1332, found 268.1333.

### 3-Ethoxy-2-phenylisoindolin-1-one (**8p**) {#sec4.4.41}

Colorless oil (42.5 mg, 84%). ^1^H NMR (400 MHz, CDCl~3~) δ 7.91 (d, *J* = 7.5 Hz, 1H), 7.84 (d, *J* = 7.7 Hz, 2H), 7.69--7.55 (m, 3H), 7.44 (t, *J* = 8.0 Hz, 2H), 7.27--7.22 (m, 1H), 6.47 (s, 1H), 3.23 (dt, *J* = 14.1, 7.1 Hz, 1H), 3.02 (dq, *J* = 14.2, 7.1 Hz, 1H), 1.03 (t, *J* = 7.0 Hz, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 166.66, 140.49, 137.50, 132.73, 130.19, 129.07, 125.26, 123.89, 123.33, 121.77, 87.13, 57.68, 14.96. HRMS (ESI) calcd for C~16~H~16~NO~2~ \[M + H\]^+^ 254.1176, found 254.1178.

### 2-(4-Chlorophenethyl)-3-ethoxyisoindolin-1-one (**8q**) {#sec4.4.42}

Colorless oil (53.6 mg, 85%). ^1^H NMR (400 MHz, CDCl~3~) δ 7.82 (d, *J* = 7.2 Hz, 1H), 7.54 (dt, *J* = 23.4, 6.9 Hz, 3H), 7.27--7.14 (m, 4H), 5.66 (s, 1H), 4.11--3.92 (m, 1H), 3.57--3.39 (m, 1H), 3.10 (dd, *J* = 15.1, 8.0 Hz, 1H), 3.07--2.87 (m, 3H), 1.11 (t, *J* = 7.0 Hz, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.57, 140.98, 137.25, 132.79, 132.34, 132.00, 130.13, 129.87, 128.73, 123.44, 123.36, 86.35, 57.74, 40.84, 33.83, 15.07. HRMS (ESI) calcd for C~18~H~19~ClNO~2~ \[M + H\]^+^ 316.1099, found 316.1099.

### 2-(4-Chlorophenyl)-3-ethoxyisoindolin-1-one (**8r**) {#sec4.4.43}

Colorless oil (49.9 mg, 87%). ^1^H NMR (400 MHz, CDCl~3~) δ 7.86 (dd, *J* = 17.9, 8.2 Hz, 3H), 7.71--7.51 (m, 3H), 7.38 (d, *J* = 8.8 Hz, 2H), 6.41 (s, 1H), 3.29--2.86 (m, 2H), 1.02 (t, *J* = 7.0 Hz, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 166.53, 140.25, 136.21, 132.95, 132.47, 130.29, 130.24, 129.07, 123.91, 123.35, 122.42, 122.39, 86.94, 57.58, 14.94. HRMS (ESI) calcd for C~16~H~15~ClNO~2~ \[M + H\]^+^ 288.0786, found 288.0786.

### 2-Benzyl-3-(3-chloropropoxy)isoindolin-1-one (**8s**) {#sec4.4.44}

Colorless oil (57.3 mg, 91%). ^1^H NMR (400 MHz, CDCl~3~) δ 7.86 (d, *J* = 7.2 Hz, 1H), 7.58--7.45 (m, 3H), 7.38--7.23 (m, 5H), 5.71 (s, 1H), 5.15 (d, *J* = 14.7 Hz, 1H), 4.29 (d, *J* = 14.7 Hz, 1H), 3.59 (t, *J* = 6.3 Hz, 2H), 3.24 (dt, *J* = 9.3, 5.8 Hz, 1H), 3.08--2.99 (m, 1H), 1.86 (dd, *J* = 11.7, 5.6 Hz, 2H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.35, 140.79, 136.95, 132.71, 132.20, 130.01, 128.76, 128.60, 127.70, 123.72, 123.44, 85.48, 58.60, 43.42, 41.51, 32.21. HRMS (ESI) calcd for C~18~H~19~ClNO~2~ \[M + H\]^+^ 316.1099, found 316.1097.

### 2-Benzyl-3-(ethylthio)isoindolin-1-one (**10a**) {#sec4.4.45}

Colorless oil (52.1 mg, 92%). ^1^H NMR (400 MHz, CDCl~3~) δ 7.87 (d, *J* = 7.5 Hz, 1H), 7.57 (s, 2H), 7.51--7.44 (m, 1H), 7.30 (dq, *J* = 13.7, 7.3 Hz, 5H), 5.38 (d, *J* = 14.7 Hz, 1H), 5.28 (s, 1H), 4.39 (d, *J* = 14.7 Hz, 1H), 1.96 (dd, *J* = 12.3, 7.5 Hz, 1H), 1.87--1.79 (m, 1H), 0.96 (t, *J* = 7.5 Hz, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.33, 143.66, 136.91, 132.16, 131.95, 128.86, 128.79, 128.60, 127.67, 123.61, 123.56, 62.85, 42.85, 20.21, 14.14. HRMS (ESI) calcd for C~17~H~18~NSO \[M + H\]^+^ 284.1104, found 284.1102.

### 2-Isopropyl-3-(propylthio)isoindolin-1-one (**10b**) {#sec4.4.46}

Colorless oil (54.1 mg, 91%). ^1^H NMR (400 MHz, CDCl~3~) δ 7.78 (d, *J* = 7.5 Hz, 1H), 7.56 (t, *J* = 6.1 Hz, 2H), 7.45 (ddd, *J* = 8.0, 4.6, 3.6 Hz, 1H), 5.57 (s, 1H), 4.34 (dt, *J* = 13.8, 6.9 Hz, 1H), 2.00 (dt, *J* = 11.9, 7.4 Hz, 1H), 1.76 (dt, *J* = 11.9, 7.2 Hz, 1H), 1.52 (dd, *J* = 14.7, 6.9 Hz, 6H), 1.29 (dt, *J* = 14.3, 7.2 Hz, 2H), 0.79 (t, *J* = 7.3 Hz, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.72, 143.71, 132.71, 131.75, 128.66, 123.17, 123.03, 63.23, 45.47, 27.85, 22.06, 20.52, 20.04, 13.59. HRMS (ESI) calcd for C~14~H~20~NOS \[M + H\]^+^ 250.1260, found 250.1261.

### 2-Benzyl-3-(propylthio)isoindolin-1-one (**10c**) {#sec4.4.47}

Colorless oil (56.0 mg, 90%). ^1^H NMR (400 MHz, CDCl~3~) δ 7.87 (d, *J* = 7.5 Hz, 1H), 7.57 (d, *J* = 12.6 Hz, 2H), 7.52--7.43 (m, 1H), 7.29 (ddd, *J* = 22.2, 13.8, 6.9 Hz, 5H), 5.37 (d, *J* = 14.7 Hz, 1H), 5.27 (s, 1H), 4.39 (d, *J* = 14.7 Hz, 1H), 1.90 (dt, *J* = 12.3, 7.4 Hz, 1H), 1.82--1.69 (m, 1H), 1.28 (dt, *J* = 14.5, 7.2 Hz, 2H), 0.80 (t, *J* = 7.3 Hz, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.35, 143.69, 136.91, 132.10, 131.95, 128.85, 128.78, 128.60, 127.66, 123.60, 123.52, 62.70, 42.85, 28.02, 22.36, 13.59. HRMS (ESI) calcd for C~19~H~22~NOS \[M + H\]^+^ 312.1417, found 312.1418.

### 2-Benzyl-3-(pentylthio)isoindolin-1-one (**10d**) {#sec4.4.48}

Colorless oil (56.6 mg, 87%). ^1^H NMR (400 MHz, CDCl~3~) δ 7.87 (d, *J* = 7.5 Hz, 1H), 7.57 (d, *J* = 5.1 Hz, 2H), 7.48 (dd, *J* = 9.0, 3.8 Hz, 1H), 7.37--7.23 (m, 5H), 5.37 (d, *J* = 14.7 Hz, 1H), 5.27 (s, 1H), 4.38 (d, *J* = 14.7 Hz, 1H), 1.92 (dt, *J* = 12.3, 7.3 Hz, 1H), 1.83--1.68 (m, 1H), 1.26 (d, *J* = 5.9 Hz, 2H), 1.20--1.10 (m, 4H), 0.79 (t, *J* = 6.7 Hz, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.36, 143.70, 136.92, 132.09, 131.96, 128.84, 128.81, 128.78, 128.60, 127.66, 123.59, 123.52, 62.74, 42.85, 31.03, 28.59, 25.94, 22.06, 13.85. HRMS (ESI) calcd for C~20~H~24~NOS \[M + H\]^+^ 326.1573, found 326.1574.

### 2-Benzyl-3-(heptylthio)isoindolin-1-one (**10e**) {#sec4.4.49}

Colorless oil (60.0 mg, 85%). ^1^H NMR (400 MHz, CDCl~3~) δ 7.87 (d, *J* = 7.5 Hz, 1H), 7.56 (d, *J* = 5.0 Hz, 2H), 7.51--7.42 (m, 1H), 7.29 (ddd, *J* = 22.5, 14.0, 7.1 Hz, 5H), 5.37 (d, *J* = 14.7 Hz, 1H), 5.27 (s, 1H), 4.38 (d, *J* = 14.7 Hz, 1H), 1.93 (dt, *J* = 12.4, 7.3 Hz, 1H), 1.83--1.72 (m, 1H), 1.19 (ddd, *J* = 30.5, 14.7, 7.1 Hz, 10H), 0.85 (t, *J* = 7.1 Hz, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.35, 143.70, 136.93, 132.08, 131.97, 128.83, 128.78, 128.60, 127.65, 123.59, 123.52, 62.75, 42.85, 31.57, 29.91, 29.82, 29.63, 25.97, 22.53, 14.06 (s). HRMS (ESI) calcd for C~22~H~28~NOS \[M + H\]^+^ 354.1886, found 354.1885.

### 2-Benzyl-3-(isopropylthio)isoindolin-1-one (**10f**) {#sec4.4.50}

Colorless oil (54.6 mg, 92%). ^1^H NMR (400 MHz, CDCl~3~) δ 7.88 (d, *J* = 7.5 Hz, 1H), 7.56 (t, *J* = 6.1 Hz, 2H), 7.52--7.44 (m, 1H), 7.28 (dq, *J* = 18.4, 7.0 Hz, 5H), 5.40 (d, *J* = 14.7 Hz, 1H), 5.31 (s, 1H), 4.42 (d, *J* = 14.7 Hz, 1H), 2.34 (dt, *J* = 13.6, 6.8 Hz, 1H), 1.11 (d, *J* = 6.8 Hz, 3H), 0.90 (d, *J* = 6.9 Hz, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.25, 143.88, 136.92, 132.02, 131.79, 128.87, 128.81, 128.52, 127.66, 123.80, 123.66, 63.20, 42.88, 32.51, 24.92, 24.34. HRMS (ESI) calcd for C~18~H~20~NOS \[M + H\]^+^ 298.1260, found 298.1261.

### 2-Benzyl-3-(cyclopentylthio)isoindolin-1-one (**10g**) {#sec4.4.51}

Colorless oil (59.4 mg, 92%). ^1^H NMR (400 MHz, CDCl~3~) δ 7.88 (d, *J* = 7.5 Hz, 1H), 7.56 (dd, *J* = 7.0, 5.5 Hz, 2H), 7.50--7.39 (m, 1H), 7.38--7.16 (m, 5H), 5.39 (d, *J* = 14.7 Hz, 1H), 5.29 (s, 1H), 4.42 (d, *J* = 14.7 Hz, 1H), 2.32 (dd, *J* = 15.3, 7.8 Hz, 1H), 1.78--1.67 (m, 1H), 1.65--1.46 (m, 2H), 1.43--1.23 (m, 4H), 1.19--1.09 (m, 1H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.28, 144.10, 136.94, 131.95, 131.76, 128.79, 128.75, 128.61, 128.58, 128.56, 127.65, 123.83, 123.63, 63.24, 42.90, 39.66, 34.56, 34.10, 24.72, 24.44. HRMS (ESI) calcd for C~20~H~22~NOS \[M + H\]^+^ 324.1417, found 324.1418.

### 2-Benzyl-3-(isobutylthio)isoindolin-1-one (**10h**) {#sec4.4.52}

Colorless oil (54.1 mg, 87%). ^1^H NMR (400 MHz, CDCl~3~) δ 7.87 (d, *J* = 7.5 Hz, 1H), 7.60--7.51 (m, 2H), 7.51--7.44 (m, 1H), 7.30 (ddd, *J* = 22.5, 13.9, 7.0 Hz, 5H), 5.37 (d, *J* = 14.7 Hz, 1H), 5.28 (s, 1H), 4.37 (d, *J* = 14.7 Hz, 1H), 1.80 (dd, *J* = 12.0, 6.7 Hz, 1H), 1.63 (dd, *J* = 11.9, 6.9 Hz, 1H), 1.46 (dt, *J* = 13.3, 6.7 Hz, 1H), 0.81 (t, *J* = 6.2 Hz, 6H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.39, 143.64, 136.91, 132.10, 131.98, 128.85, 128.81, 128.78, 128.61, 127.67, 123.59, 123.49, 62.59, 42.85, 34.60, 28.07, 22.14, 22.08. HRMS (ESI) calcd for C~19~H~22~NOS \[M + H\]^+^ 312.1417, found 312.1417.

### 2-Benzyl-3-(benzylthio)isoindolin-1-one (**10i**) {#sec4.4.53}

Colorless oil (64.2 mg, 93%). ^1^H NMR (400 MHz, CDCl~3~) δ 7.89 (d, *J* = 7.2 Hz, 1H), 7.55--7.45 (m, 3H), 7.33--7.24 (m, 5H), 7.21--7.12 (m, 3H), 6.95 (d, *J* = 6.9 Hz, 2H), 5.30 (s, 1H), 5.22 (d, *J* = 14.8 Hz, 1H), 4.26 (d, *J* = 14.8 Hz, 1H), 3.09 (d, *J* = 2.8 Hz, 2H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.25, 143.15, 137.04, 136.90, 132.22, 132.08, 129.02, 128.83, 128.80, 128.75, 128.61, 128.50, 127.70, 127.12, 123.68, 123.59, 63.24, 42.89, 31.29. HRMS (ESI) calcd for C~22~H~20~NOS \[M + H\]^+^ 346.1260, found 346.1261.

### 2-Benzyl-3-((4-methylbenzyl)thio)isoindolin-1-one (**10j**) {#sec4.4.54}

Colorless oil (67.5 mg, 94%). H NMR (400 MHz, CDCl~3~) δ 7.88 (d, *J* = 7.3 Hz, 1H), 7.50 (tt, *J* = 14.1, 7.3 Hz, 3H), 7.35--7.21 (m, 5H), 7.00 (d, *J* = 7.8 Hz, 2H), 6.84 (d, *J* = 7.9 Hz, 2H), 5.31--5.19 (m, 2H), 4.28 (d, *J* = 14.8 Hz, 1H), 3.12--3.00 (m, 2H), 2.27 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.28, 143.29, 136.95, 136.79, 133.82, 132.21, 132.08, 129.21, 128.97, 128.82, 128.70, 128.68, 128.65, 128.62, 127.69, 123.68, 123.58, 63.26, 42.92, 31.01, 21.13. HRMS (ESI) calcd for C~23~H~22~NOS \[M + H\]^+^ 360.1417, found 360.1417.

### 2-Benzyl-3-((4-chlorobenzyl)thio)isoindolin-1-one (**10k**) {#sec4.4.55}

Colorless oil (69.7 mg, 92%). ^1^H NMR (400 MHz, CDCl~3~) δ 7.88 (d, *J* = 6.9 Hz, 1H), 7.53--7.43 (m, 3H), 7.33--7.24 (m, 5H), 7.13 (d, *J* = 8.3 Hz, 2H), 6.84 (d, *J* = 8.3 Hz, 2H), 5.30 (s, 1H), 5.23 (d, *J* = 14.8 Hz, 1H), 4.26 (d, *J* = 14.8 Hz, 1H), 3.05 (q, *J* = 13.3 Hz, 2H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.25, 142.98, 136.78, 135.72, 132.86, 132.26, 131.98, 130.04, 129.08, 128.85, 128.62, 128.58, 128.57, 128.54, 127.75, 123.68, 123.62, 63.19, 42.97, 30.51. HRMS (ESI) calcd for C~22~H~19~ClNOS \[M + H\]^+^ 380.0870, found 380.0872.

### 2-Benzyl-3-((4-(*tert*-butyl)benzyl)thio)isoindolin-1-one (**10l**) {#sec4.4.56}

Colorless oil (73.1 mg, 90%). ^1^H NMR (400 MHz, CDCl~3~) δ 7.87 (d, *J* = 6.9 Hz, 1H), 7.54--7.40 (m, 3H), 7.37--7.21 (m, 5H), 7.22--7.13 (m, 2H), 6.89 (d, *J* = 8.1 Hz, 2H), 5.27 (d, *J* = 15.7 Hz, 2H), 4.31 (d, *J* = 14.7 Hz, 1H), 3.08 (dd, *J* = 28.7, 12.9 Hz, 2H), 1.27 (s, 9H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.33, 150.03, 143.31, 136.97, 133.84, 132.16, 132.03, 128.95, 128.84, 128.66, 128.64, 128.48, 127.70, 125.42, 123.69, 123.56, 63.25, 42.93, 34.49, 31.36, 30.84. HRMS (ESI) calcd for C~26~H~28~NOS \[M + H\]^+^ 402.1886, found 402.1886.

### Ethyl 2-((2-Benzyl-3-oxoisoindolin-1-yl)thio)acetate (**10m**) {#sec4.4.57}

Colorless oil (58.0 mg, 85%). ^1^H NMR (400 MHz, CDCl~3~) δ 7.88 (d, *J* = 7.5 Hz, 1H), 7.67--7.44 (m, 3H), 7.37--7.16 (m, 5H), 5.35 (d, *J* = 16.0 Hz, 2H), 4.37 (d, *J* = 14.8 Hz, 1H), 3.98 (tdd, *J* = 10.8, 7.2, 3.6 Hz, 2H), 2.66 (q, *J* = 15.3 Hz, 2H), 1.16 (t, *J* = 7.1 Hz, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 169.40, 167.10, 142.13, 136.69, 132.26, 132.21, 129.28, 128.85, 128.57, 127.75, 123.77, 123.67, 62.69, 61.75, 42.89, 28.82, 13.95. HRMS (ESI) calcd for C~19~H~20~NO~3~S \[M + H\]^+^ 342.1158, found 342.1159.

### 4-((1-Oxo-3-(propylthio)isoindolin-2-yl)methyl)benzonitrile (**10n**) {#sec4.4.58}

Colorless oil (58.6 mg, 91%). ^1^H NMR (400 MHz, CDCl~3~) δ 7.88 (d, *J* = 7.6 Hz, 1H), 7.66--7.57 (m, 4H), 7.55--7.45 (m, 3H), 5.33 (d, *J* = 15.2 Hz, 1H), 5.29 (s, 1H), 4.53 (d, *J* = 15.1 Hz, 1H), 1.90--1.72 (m, 2H), 1.28 (dd, *J* = 14.6, 7.3 Hz, 2H), 0.80 (t, *J* = 7.3 Hz, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.56, 143.45, 142.41, 132.59, 132.49, 131.44, 129.18, 129.11, 123.68, 118.56, 111.65, 63.05, 42.73, 28.02, 22.23, 13.53. HRMS (ESI) calcd for C~19~H~19~N~2~OS \[M + H\]^+^ 323.1213, found 323.1213.

### 2-Phenyl-3-(propylthio)isoindolin-1-one (**10o**) {#sec4.4.59}

Colorless oil (48.1 mg, 85%). ^1^H NMR (400 MHz, CDCl~3~) δ 7.92 (d, *J* = 7.6 Hz, 1H), 7.58 (ddt, *J* = 35.2, 28.4, 8.0 Hz, 7H), 7.27 (d, *J* = 8.4 Hz, 1H), 6.13 (s, 1H), 1.98 (dt, *J* = 12.2, 7.3 Hz, 1H), 1.82 (dt, *J* = 12.2, 7.4 Hz, 1H), 1.32--1.13 (m, 2H), 0.70 (t, *J* = 7.3 Hz, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 166.58, 143.07, 136.52, 132.66, 131.97, 129.16, 129.13, 128.97, 125.94, 124.09, 123.84, 123.77, 123.61, 64.68, 28.66, 22.19, 13.43. HRMS (ESI) calcd for C~17~H~18~NOS \[M + H\]^+^ 284.1104, found 284.1105.

### 3-(Propylthio)-2-(*p*-tolyl)isoindolin-1-one (**10p**) {#sec4.4.60}

Colorless oil (48.1 mg, 85%). ^1^H NMR (400 MHz, CDCl~3~) δ 7.90 (d, *J* = 7.6 Hz, 1H), 7.66 (q, *J* = 7.7 Hz, 2H), 7.53 (t, *J* = 7.2 Hz, 1H), 7.46 (d, *J* = 8.9 Hz, 2H), 7.00 (d, *J* = 8.9 Hz, 2H), 6.03 (s, 1H), 3.84 (s, 3H), 2.00 (dt, *J* = 12.2, 7.3 Hz, 1H), 1.83 (dt, *J* = 12.2, 7.4 Hz, 1H), 1.33--1.11 (m, 2H), 0.72 (t, *J* = 7.3 Hz, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 166.66, 157.85, 143.06, 132.46, 129.10, 126.07, 123.76, 123.59, 114.35, 65.41, 55.47, 28.77, 22.22, 13.47. HRMS (ESI) calcd for C~18~H~20~NOS \[M + H\]^+^ 298.1260, found 298.1262.

### 2-Phenethyl-3-(propylthio)isoindolin-1-one (**10q**) {#sec4.4.61}

Colorless oil (54.1 mg, 87%). ^1^H NMR (400 MHz, CDCl~3~) δ 1H NMR (400 MHz, CDCl3) δ 7.83 (d, *J* = 7.5 Hz, 1H), 7.62--7.50 (m, 2H), 7.50--7.39 (m, 1H), 7.29--7.13 (m, 5H), 5.20 (s, 1H), 4.22 (ddd, *J* = 14.1, 8.2, 6.3 Hz, 1H), 3.73--3.57 (m, 1H), 3.12--2.88 (m, 2H), 1.77 (dtd, *J* = 14.3, 12.3, 7.4 Hz, 2H), 1.24 (dt, *J* = 14.6, 7.3 Hz, 2H), 0.77 (t, *J* = 7.3 Hz, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.50, 143.60, 138.75, 132.12, 131.95, 128.79, 128.77, 128.63, 126.56, 123.48, 123.26, 63.92, 40.84, 34.56, 28.07, 22.30, 13.54. HRMS (ESI) calcd for C~19~H~22~NOS \[M + H\]^+^ 312.1417, found 312.1418.

### 2-(4-Chlorophenethyl)-3-(propylthio)isoindolin-1-one (**10r**) {#sec4.4.62}

Colorless oil (60.7 mg, 88%). ^1^H NMR (400 MHz, CDCl~3~) δ 7.82 (d, *J* = 7.5 Hz, 1H), 7.58 (d, *J* = 4.8 Hz, 2H), 7.55--7.43 (m, 1H), 7.32--7.15 (m, 4H), 5.24 (s, 1H), 4.19 (ddd, *J* = 14.2, 8.2, 6.4 Hz, 1H), 3.76--3.42 (m, 1H), 3.11--2.80 (m, 2H), 1.77 (ddt, *J* = 45.9, 12.2, 7.4 Hz, 2H), 1.25 (dt, *J* = 14.6, 7.3 Hz, 2H), 0.77 (t, *J* = 7.3 Hz, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.52, 143.48, 137.17, 132.37, 132.05, 131.98, 130.13, 128.87, 128.75, 123.52, 123.29, 63.86, 40.62, 33.86, 28.01, 22.27, 13.53. HRMS (ESI) calcd for C~19~H~21~ClNOS \[M + H\]^+^ 346.1027, found 346.1028.

### 2-(4-Methoxybenzyl)-3-(propylthio)isoindolin-1-one (**10s**) {#sec4.4.63}

Colorless oil (51.7 mg, 84%). ^1^H NMR (400 MHz, CDCl~3~) δ 7.86 (d, *J* = 7.5 Hz, 1H), 7.62--7.52 (m, 2H), 7.5--7.41 (m, 1H), 7.28 (t, *J* = 6.4 Hz, 2H), 6.84 (d, *J* = 8.6 Hz, 2H), 5.31 (d, *J* = 14.5 Hz, 1H), 5.26 (s, 1H), 4.32 (d, *J* = 14.5 Hz, 1H), 3.77 (s, 3H), 1.83 (ddt, *J* = 53.5, 12.2, 7.4 Hz, 2H), 1.29 (dt, *J* = 14.4, 7.2 Hz, 2H), 0.81 (t, *J* = 7.3 Hz, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.27, 159.13, 143.69, 132.04, 129.97, 129.07, 128.81, 123.55, 123.47, 114.13, 62.56, 55.28, 42.23, 27.97, 22.35, 13.57. HRMS (ESI) calcd for C~19~H~22~NO~2~S \[M + H\]^+^ 328.1366, found 328.1365.

### 2-(4-Methylphenethyl)-3-(propylthio)isoindolin-1-one (**10t**) {#sec4.4.64}

Colorless oil (53.3 mg, 82%). ^1^H NMR (400 MHz, CDCl~3~) δ 7.82 (d, *J* = 7.5 Hz, 1H), 7.55 (s, 2H), 7.51--7.37 (m, 1H), 7.11 (dd, *J* = 25.2, 7.8 Hz, 4H), 5.23 (s, 1H), 4.20 (ddd, *J* = 14.1, 8.1, 6.4 Hz, 1H), 3.71--3.54 (m, 1H), 3.04--2.81 (m, 2H), 2.30 (s, 3H), 1.77 (ddt, *J* = 26.8, 12.3, 7.4 Hz, 2H), 1.24 (dt, *J* = 14.6, 7.3 Hz, 2H), 0.77 (t, *J* = 7.3 Hz, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.48, 143.63, 136.03, 135.61, 132.16, 131.91, 129.31, 129.29, 128.77, 128.66, 128.63, 123.49, 123.25, 63.90, 40.89, 34.11, 28.07, 22.32, 21.06, 13.54. HRMS (ESI) calcd for C~20~H~24~NOS \[M + H\]^+^ 326.1573, found 326.1573.

### 2-Benzyl-3-thiomorpholinoisoindolin-1-one (**12a**) {#sec4.4.65}

White solid (61.6 mg, 95%), mp = 110--112 °C. ^1^H NMR (400 MHz, CDCl~3~) δ 7.88 (d, *J* = 6.8 Hz, 1H), 7.55--7.45 (m, 2H), 7.43 (d, *J* = 7.1 Hz, 1H), 7.35--7.23 (m, 5H), 5.21 (d, *J* = 14.6 Hz, 1H), 4.91 (s, 1H), 4.31 (d, *J* = 14.6 Hz, 1H), 3.03--2.65 (m, 4H), 2.59 (d, *J* = 4.4 Hz, 4H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.46, 142.07, 137.45, 132.72, 131.52, 129.15, 128.69, 128.44, 127.52, 123.82, 123.36, 78.71, 50.07, 43.62, 28.54. HRMS (ESI) calcd for C~19~H~21~N~2~OS \[M + H\]^+^ 325.1369, found 325.1370.

### 2-Benzyl-3-morpholinoisoindolin-1-one (**12b**)^[@ref29]^ {#sec4.4.66}

White solid (57.3 mg, 93%), mp = 130--131 °C. ^1^H NMR (400 MHz, CDCl~3~) δ 7.89 (d, *J* = 6.6 Hz, 1H), 7.48 (dt, *J* = 13.8, 6.5 Hz, 3H), 7.36--7.18 (m, 5H), 5.22 (d, *J* = 14.6 Hz, 1H), 4.96 (s, 1H), 4.34 (d, *J* = 14.6 Hz, 1H), 3.65 (t, *J* = 4.4 Hz, 4H), 2.73--2.55 (m, 2H), 2.52--2.27 (m, 2H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.44, 141.87, 137.44, 132.80, 131.43, 129.17, 128.67, 128.52, 127.51, 123.89, 123.49, 77.38, 67.34, 47.64, 43.61. HRMS (ESI) calcd for C~20~H~24~NO~2~ \[M + H\]^+^ 326.1573, found 326.1574.

### 2-Benzyl-3-(benzylamino)isoindolin-1-one (**12c**) {#sec4.4.67}

Colorless oil (59.0 mg, 90%). ^1^H NMR (400 MHz, CDCl~3~) δ 7.88 (d, *J* = 7.3 Hz, 1H), 7.59--7.41 (m, 3H), 7.27 (tt, *J* = 10.6, 7.4 Hz, 8H), 7.15 (d, *J* = 7.1 Hz, 2H), 5.32 (s, 1H), 5.17 (d, *J* = 15.0 Hz, 1H), 4.34 (d, *J* = 15.0 Hz, 1H), 3.35 (d, *J* = 13.0 Hz, 1H), 3.24 (d, *J* = 13.0 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.75, 143.31, 139.67, 137.42, 132.84, 131.89, 129.19, 128.85, 128.44, 128.29, 128.09, 128.09, 127.63, 127.20, 123.56, 123.22, 72.33, 45.60, 43.26. HRMS (ESI) calcd for C~22~H~21~N~2~O \[M + H\]^+^ 329.1648, found 329.1648.

### 2-Benzyl-3-((4-fluorobenzyl)amino)isoindolin-1-one **(12d**) {#sec4.4.68}

Colorless oil (56.1 mg, 81%). ^1^H NMR (400 MHz, CDCl~3~) δ 7.88 (d, *J* = 7.2 Hz, 1H), 7.57--7.44 (m, 3H), 7.37--7.20 (m, 5H), 7.08 (dd, *J* = 8.2, 5.7 Hz, 2H), 6.92 (t, *J* = 8.6 Hz, 2H), 5.33 (s, 1H), 5.13 (d, *J* = 15.0 Hz, 1H), 4.38 (d, *J* = 15.0 Hz, 1H), 3.31 (d, *J* = 13.0 Hz, 1H), 3.19 (d, *J* = 13.0 Hz, 1H), 2.16 (s, 1H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.76, 161.98 (d, *J* = 244 Hz), 143.18, 137.40, 135.39 (d, *J* = 2.7 Hz), 132.79, 131.91, 129.62 (d, *J* = 7.9 Hz), 129.22, 128.86, 128.26, 128.22, 127.66, 123.57, 123.18, 115.26, 115.05, 72.38, 44.80, 43.37. HRMS (ESI) calcd for C~22~H~20~FN~2~O \[M + H\]^+^ 347.1154, found 347.1155.

### 2-Benzyl-3-((4-chlorobenzyl)amino)isoindolin-1-one (**12e**) {#sec4.4.69}

Colorless oil (61.5 mg, 85%). ^1^H NMR (400 MHz, CDCl~3~) δ 7.87 (d, *J* = 7.1 Hz, 1H), 7.57--7.43 (m, 3H), 7.39--7.15 (m, 7H), 7.04 (d, *J* = 8.3 Hz, 2H), 5.33 (s, 1H), 5.11 (d, *J* = 15.0 Hz, 1H), 4.38 (d, *J* = 15.0 Hz, 1H), 3.24 (dd, *J* = 47.1, 13.3 Hz, 2H), 2.17 (s, 1H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.75, 143.11, 138.20, 137.38, 132.84, 132.78, 131.93, 129.40, 129.25, 128.86, 128.46, 128.25, 127.67, 123.58, 123.18, 72.40, 44.84, 43.40. HRMS (ESI) calcd for C~22~H~20~ClN~2~O \[M + H\]^+^ 363.1259, found 363.1260.

### 2-Benzyl-3-((4-bromobenzyl)amino)isoindolin-1-one (**12f**) {#sec4.4.70}

Colorless oil (70.6 mg, 87%). ^1^H NMR (400 MHz, CDCl~3~) δ 7.88 (d, *J* = 7.1 Hz, 1H), 7.63--7.45 (m, 3H), 7.42--7.21 (m, 7H), 6.99 (d, *J* = 8.2 Hz, 2H), 5.33 (s, 1H), 5.12 (d, *J* = 15.0 Hz, 1H), 4.38 (d, *J* = 15.0 Hz, 1H), 3.23 (dd, *J* = 48.1, 13.3 Hz, 2H), 2.12 (s, 1H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.75, 143.06, 138.67, 137.34, 132.77, 131.94, 131.43, 129.75, 129.26, 128.87, 128.25, 127.68, 123.60, 123.16, 120.94, 72.37, 44.88, 43.42. HRMS (ESI) calcd for C~22~H~20~BrN~2~O \[M + H\]^+^ 407.0754, found 407.0755.

### 2-Benzyl-3-((2-chlorobenzyl)amino)isoindolin-1-one (**12g**) {#sec4.4.71}

Colorless oil (60.8 mg, 84%). ^1^H NMR (400 MHz, CDCl~3~) δ 7.89 (d, *J* = 6.8 Hz, 1H), 7.51 (dt, *J* = 13.7, 6.0 Hz, 3H), 7.35--7.22 (m, 6H), 7.16 (p, *J* = 6.9 Hz, 2H), 7.10--7.02 (m, 1H), 5.30 (s, 1H), 5.18 (d, *J* = 15.0 Hz, 1H), 4.25 (d, *J* = 15.0 Hz, 1H), 3.44 (dd, *J* = 67.5, 13.4 Hz, 2H), 2.35 (s, 1H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.62, 143.11, 137.35, 137.31, 133.78, 132.85, 131.86, 130.39, 129.49, 129.23, 128.84, 128.63, 128.28, 127.61, 126.97, 123.54, 123.27, 72.12, 43.71, 43.06. HRMS (ESI) calcd for C~22~H~20~ClN~2~O \[M + H\]^+^ 363.1259, found 363.1259.

### 2-Benzyl-3-(pentylthio)isoindolin-1-one (**12h**) {#sec4.4.72}

Colorless oil (62.9 mg, 92%). ^1^H NMR \[400 MHz, dimethyl sulfoxide (DMSO)-*d*~6~\] δ 7.76 (d, *J* = 7.4 Hz, 1H), 7.62 (s, 2H), 7.57--7.50 (m, 1H), 7.40 (d, *J* = 7.3 Hz, 2H), 7.33 (t, *J* = 7.4 Hz, 2H), 7.26 (t, *J* = 7.2 Hz, 1H), 7.08 (d, *J* = 10.3 Hz, 4H), 5.43 (d, *J* = 4.8 Hz, 1H), 4.90 (d, *J* = 15.1 Hz, 1H), 4.50 (d, *J* = 15.1 Hz, 1H), 3.80--3.60 (m, 1H), 3.22 (dd, *J* = 12.8, 4.3 Hz, 1H), 2.99 (dd, *J* = 12.7, 8.7 Hz, 1H), 2.13 (s, 3H). ^13^C NMR (100 MHz, DMSO-*d*~6~) δ 167.23, 144.30, 138.68, 138.43, 136.49, 133.02, 132.23, 130.18, 129.48, 129.22, 128.93, 128.43, 127.52, 127.17, 126.00, 123.99, 123.02, 73.03, 42.80, 42.71, 18.96. HRMS (ESI) calcd for C~23~H~23~N~2~O \[M + H\]^+^ 343.1805, found 343.1805.

### 2-Benzyl-3-((furan-2-ylmethyl)amino)isoindolin-1-one (**12i**) {#sec4.4.73}

Colorless oil (59.8 mg, 94%). ^1^H NMR (400 MHz, CDCl~3~) δ 7.88 (d, *J* = 7.3 Hz, 1H), 7.60--7.44 (m, 3H), 7.38--7.22 (m, 5H), 7.22--7.11 (m, 1H), 6.88 (dd, *J* = 5.0, 3.5 Hz, 1H), 6.71 (d, *J* = 2.7 Hz, 1H), 5.31 (s, 1H), 5.19 (d, *J* = 15.0 Hz, 1H), 4.35 (d, *J* = 15.0 Hz, 1H), 3.61 (d, *J* = 13.9 Hz, 1H), 3.43 (d, *J* = 13.9 Hz, 1H), 2.26 (s, 1H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.67, 143.39, 142.99, 137.30, 132.73, 131.95, 129.26, 128.86, 128.29, 127.67, 126.67, 124.83, 124.70, 123.59, 123.19, 71.95, 43.28, 40.65. HRMS (ESI) calcd for C~20~H~19~N~2~O~2~ \[M + H\]^+^ 319.1441, found 319.1442.

### 2-Phenyl-3-thiomorpholinoisoindolin-1-one (**12j**) {#sec4.4.74}

White solid (55.8 mg, 90%), mp = 101--103 °C. ^1^H NMR (400 MHz, CDCl~3~) δ 7.89 (d, *J* = 7.4 Hz, 1H), 7.66--7.58 (m, 1H), 7.58--7.48 (m, 4H), 7.44 (t, *J* = 7.8 Hz, 2H), 7.27 (dd, *J* = 9.7, 4.9 Hz, 1H), 5.85 (s, 1H), 3.02--2.82 (m, 2H), 2.74--2.56 (m, 2H), 2.58--2.35 (m, 4H). ^13^C NMR (100 MHz, CDCl~3~) δ 166.81, 142.05, 138.08, 132.59, 132.30, 129.52, 129.08, 126.24, 125.15, 123.86, 123.39, 81.76, 50.44, 28.46. HRMS (ESI) calcd for C~18~H~19~N~2~OS \[M + H\]^+^ 311.1213, found 311.1213.

### 3-Thiomorpholino-2-(*p*-tolyl)isoindolin-1-one (**12k**) {#sec4.4.75}

White solid (54.9 mg, 88%), mp = 95--97 °C. ^1^H NMR (400 MHz, CDCl~3~) δ 7.88 (d, *J* = 7.4 Hz, 1H), 7.55 (tt, *J* = 14.2, 7.2 Hz, 3H), 7.36 (d, *J* = 8.2 Hz, 2H), 7.24 (t, *J* = 9.1 Hz, 2H), 5.80 (s, 1H), 2.97--2.81 (m, 2H), 2.70--2.58 (m, 2H), 2.55--2.40 (m, 4H), 2.38 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 166.85, 142.15, 136.14, 135.45, 132.70, 132.18, 129.74, 129.44, 125.23, 123.75, 123.36, 81.92, 50.47, 28.48, 21.12. HRMS (ESI) calcd for C~19~H~21~N~2~OS \[M + H\]^+^ 325.1369, found 325.1369.

### 2-Isopropyl-3-thiomorpholinoisoindolin-1-one (**12l**) {#sec4.4.76}

White solid (46.9 mg, 85%), mp = 94--95 °C. ^1^H NMR (400 MHz, CDCl~3~) δ 7.79 (d, *J* = 7.0 Hz, 1H), 7.48 (dt, *J* = 19.2, 6.4 Hz, 3H), 5.13 (s, 1H), 4.31 (dt, *J* = 13.7, 6.8 Hz, 1H), 3.25--2.35 (m, 8H), 1.43 (dd, *J* = 15.3, 6.9 Hz, 6H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.32, 141.60, 133.28, 131.06, 128.96, 123.40, 123.07, 79.46, 44.43, 28.36, 21.42, 19.82. HRMS (ESI) calcd for C~15~H~21~N~2~OS \[M + H\]^+^ 277.1369, found 277.1369.

### 2-Phenethyl-3-thiomorpholinoisoindolin-1-one (**12m**) {#sec4.4.77}

White solid (62.2 mg, 92%), mp = 90--91 °C. ^1^H NMR (400 MHz, CDCl~3~) δ 7.87 (d, *J* = 7.5 Hz, 1H), 7.57 (d, *J* = 5.1 Hz, 2H), 7.48 (dd, *J* = 9.0, 3.8 Hz, 1H), 7.37--7.23 (m, 5H), 5.37 (d, *J* = 14.7 Hz, 1H), 5.27 (s, 1H), 4.38 (d, *J* = 14.7 Hz, 1H), 1.92 (dt, *J* = 12.3, 7.3 Hz, 1H), 1.83--1.68 (m, 1H), 1.26 (d, *J* = 5.9 Hz, 2H), 1.20--1.10 (m, 4H), 0.79 (t, *J* = 6.7 Hz, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.51, 142.09, 139.29, 132.85, 131.33, 129.06, 128.82, 128.59, 126.50, 123.51, 123.21, 79.78, 50.03, 41.14, 34.95, 28.60. HRMS (ESI) calcd for C~20~H~23~N~2~OS \[M + H\]^+^ 339.1526, found 339.1527.

### 2-(4-Methoxyphenethyl)-3-thiomorpholinoisoindolin-1-one (**12n**) {#sec4.4.78}

White solid (64.0 mg, 87%), mp = 132--134 °C. ^1^H NMR (400 MHz, CDCl~3~) δ 7.82 (d, *J* = 7.0 Hz, 1H), 7.46 (ddt, *J* = 28.7, 14.8, 6.8 Hz, 3H), 7.16 (d, *J* = 8.5 Hz, 2H), 6.83 (d, *J* = 8.5 Hz, 2H), 4.79 (s, 1H), 4.07 (ddd, *J* = 13.7, 7.8, 6.0 Hz, 1H), 3.77 (s, 3H), 3.58--3.40 (m, 1H), 3.01--2.87 (m, 2H), 2.87--2.49 (m, 8H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.48, 158.27, 142.11, 132.87, 131.31, 131.21, 129.72, 129.03, 123.46, 123.22, 114.00, 79.77, 55.27, 41.31, 33.96, 28.60. HRMS (ESI) calcd for C~21~H~25~N~2~O~2~S \[M + H\]^+^ 369.1631, found 369.1631.

### 2-(4-Chlorophenethyl)-3-thiomorpholinoisoindolin-1-one (**12o**) {#sec4.4.79}

White solid (67.0 mg, 90%), mp = 113--115 °C. ^1^H NMR (400 MHz, CDCl~3~) δ 7.82 (d, *J* = 7.1 Hz, 1H), 7.47 (ddd, *J* = 26.7, 13.1, 7.0 Hz, 3H), 7.29--7.23 (m, 2H), 7.19 (d, *J* = 8.3 Hz, 2H), 4.82 (s, 1H), 4.07 (ddd, *J* = 13.9, 7.9, 6.1 Hz, 1H), 3.64--3.38 (m, 1H), 2.96 (qd, *J* = 13.8, 6.9 Hz, 2H), 2.89--2.44 (m, 8H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.55, 141.94, 137.65, 132.71, 132.29, 131.44, 130.14, 129.14, 128.69, 123.56, 123.26, 79.79, 50.05, 40.98, 34.19, 28.58. HRMS (ESI) calcd for C~20~H~22~ClN~2~OS \[M + H\]^+^ 373.1136, found 373.1138.

### 2-(4-Fluorobenzyl)-3-thiomorpholinoisoindolin-1-one (**12p**) {#sec4.4.80}

White solid (62.9 mg, 92%), mp = 121--123 °C. ^1^H NMR (400 MHz, CDCl~3~) δ 7.87 (d, *J* = 6.9 Hz, 1H), 7.49 (ddd, *J* = 22.8, 11.5, 6.9 Hz, 3H), 7.30 (dt, *J* = 8.6, 4.4 Hz, 2H), 7.00 (t, *J* = 8.6 Hz, 2H), 5.14 (d, *J* = 14.6 Hz, 1H), 4.90 (s, 1H), 4.30 (d, *J* = 14.6 Hz, 1H), 2.69 (dd, *J* = 78.8, 24.8 Hz, 8H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.41, 162.18 (d, *J* = 254 Hz), 160.96, 141.98, 133.29 (d, *J* = 3.1 Hz), 132.59, 131.60, 130.13 (d, *J* = 8.1 Hz), 129.20, 123.82, 123.39, 115.63, 115.42, 78.72, 50.05, 42.86, 28.52. HRMS (ESI) calcd for C~19~H~20~FN~2~OS \[M + H\]^+^ 343.1275, found 343.1275.

### 2-(4-Methylbenzyl)-3-thiomorpholinoisoindolin-1-one (**12q**) {#sec4.4.81}

White solid (59.5 mg, 88%), mp = 125--127 °C. ^1^H NMR (400 MHz, CDCl~3~) δ 7.86 (d, *J* = 6.7 Hz, 1H), 7.48 (tt, *J* = 13.8, 6.8 Hz, 2H), 7.41 (d, *J* = 7.1 Hz, 1H), 7.21 (d, *J* = 7.9 Hz, 2H), 7.11 (d, *J* = 7.8 Hz, 2H), 5.19 (d, *J* = 14.5 Hz, 1H), 4.89 (s, 1H), 4.23 (d, *J* = 14.5 Hz, 1H), 2.69 (dt, *J* = 62.0, 4.5 Hz, 8H), 2.31 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ 167.36, 142.12, 137.13, 134.38, 132.78, 131.46, 129.34, 129.09, 128.42, 123.73, 123.35, 78.56, 50.05, 43.28, 28.56, 21.13. HRMS (ESI) calcd for C~20~H~24~NOS \[M + H\]^+^ 326.1573, found 326.1574.
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